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ABSTRACT

Nanotechnology is a multidisciplinary field that combines science and
engineering to design, synthesize, characterize and explore applications for materials and
devices whose smallest functional organization in at least one dimension is on the
nanometer scale. Nanotechnology is undergoing an explosive development and the extent
of potential application is vast and widely diverse. In the field o f human health care,
nanotechnology is helping to develop novel materials and structures, which have made it
possible to miniaturize many o f the tools used in conventional assays. Smart biochips
constructed out o f these novel materials and structures are now capable o f performing
limited in vitro diagnostic tests involved in immunoassays. In this work, we report two
devices that make use of micro scale and/or nano scale structures to contribute to the
ever-expanding use o f biochips in human health care.
The first device is a Patch-Clamp microchip that is capable o f monitoring cell
viability in real-time. It is critical to monitor the health o f cells in biological life science
and medical research. Researchers must know if a new drug is capable o f killing cancer
cells or in other cases to determine the toxic effects o f a drug or a pesticide on healthy
cells. Conventional cell viability monitoring techniques that use flow cytometer or
fluorescent dyes in conjunction with fluorescence microscope are time consuming and
require sample labeling. Alternatively, we have designed a patch-clamp microchip, which
allows one to measure the ion-channel currents in real-time. This microchip provides a

faster and label-free platform to monitor the health o f the cell. Simultaneously, viability
tests were performed on four different types o f cancer cells (MB231, M B231-BR-vector,
MB231-BR-HER 2, and MB231-BR) using the conventional fluorescent dye technique
and using the patch-clamp microchip technique. For the patch-clamp technique, the seal
resistance o f the device decreased from ~22 MQ (living cell) to ~4 MQ (dead cell) over a
period o f 120 minutes. Comparing the seal resistance to the intensity o f the fluorescence
images over the 120 minute period confirms a correlation between the health o f the cell
and the ion-channel current, validating our claim that the patch-clamp microchip can be
used as an alternate technical platform to the conventional techniques that use fluorescent
dyes or a flow cytometer.
The second device is a Field-Effect Transistor (FET) based biosensor used for the
detection o f biomolecules. The conventional technique, ELISA, is still the gold standard
for immunoassays. Most of the modem biosensors have exploited the semi conductive
nature o f CNT to design a label-free FET based immunosensor (biosensor that
exclusively monitors the antibody-antigen interaction). Even though biosensors made out
o f a single CNT are ideally capable o f detecting a single molecule, the fabrication o f such
devices is challenging. To avoid the fabrication complexity involved with a single CNT
based immunosensor, we have developed an FET based biosensor, in which the channel
is made out of Carbon Nanotube Thin Film (CNTF). The CNTF channel between the
source and drain electrodes is assembled using electrostatic layer-by-layer (LBL) selfassembly. The bio-affinity interaction between Protein A and rabbit IgG is used to model
the antibody-antigen interaction, and our initial results show the device is capable o f
detecting IgG concentrations as low as 1 pg/mL.
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CHAPTER 1

PATCH-CLAMP MICROCHIP: INTRODUCTION
In biological life science and medical research, it is critical to distinguish between
living and dead cells. Specifically, it is important to know if a potential cancer treatment
drug has killed the cancerous cells. In order to monitor the cells’ viability, the
colorimetric or fluorescence technique is usually used [1]—[3]. Typically, these methods
require a flow cytometer or the labeling o f cells with fluorescent dyes in conjunction with
using a fluorescence microscope to evaluate viability, making them time-inefficient
and/or cost-ineffective. In addition, these techniques are not convenient for studying the
dynamic process o f cell death in real-time. For instance, the fluorescence images o f the
cells have to be processed with image processing tools, which can sometimes render the
real-time monitoring unfeasible.
Recently, a technique measuring volume changes in single cells using a
microfluidic chip has shown great promise for real time monitoring o f treatment drug on
the cells’ viability [4]—[6]. This type o f biosensor utilizes an electrical impedance method
to monitor the volume change o f a cell. Specifically, the cells to be measured are sent
through a micro-chamber via a microfluidic network. When their volumes change, the
extra-cellular fluid in the micro-chamber will be pushed out. As a result, the electrical
resistance o f the chamber will change. Using this microfluidic chip, high throughput drug
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screening can be achieved. Therefore, a tagless technique, which offers instantaneous and
quantitative information about cell viability, becomes very attractive.
Traditional PC technology is very time consuming and requires laborious effort
with a rather low throughput. For the past decade, various types o f PC microchips have
been developed in several groups to enhance the throughput and efficiency over the
conventional glass-pipette based PC technology [7]—[11 ]. It has been demonstrated that
by using a properly designed and fabricated micropipette, some PC microchips show
reliable and consistent Gigaseal (resistance in the range o f giga ohms) capability,
indicating the possibility that the PC microchip can eventually replace the conventional
glass-pipette PC technology.
In this work, we offer an alternate viable technical platform for monitoring cell
viability in real time using a planar patch-clamp microchip [12] .

1.1

Key Accomplishments of the Project

The significant accomplishments o f this project include fabrication o f the planar
patch-clamp microchip, successful recording o f ion-channel currents in four different
types of human breast cancer cells including MDA-MB231, MDA- MB231-brain
metastatic subline (abbreviated as M B231-BR), M B231-BR over-expressing HER2 gene
(MB231-BR-HER2), and M B231-BR-vector control for the HER2 (M B231-BR-vector),
and simultaneously validating the results against the change in cell fluorescence intensity
to prove the viability o f the patch-clamp microchip technical platform. It has been
demonstrated that, even though the seal resistance o f the PC microchip is in the range o f
Mega-ohms (MQ), it is still able to monitor cell viability.
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1.2

Outline of the Patch-clamp Microchip Project

In CHAPTER 2 we begin with a discussion on ion-channels, the gating
mechanisms in ion-channels, the ion-channel assays and use o f patch-clamp technique in
these assays. We then explain the basic construction of a patch-clamp device and the
various configurations it can be employed. The chapter ends with a discussion on the
planar patch-clamp structure, its significance, cell viability and how the planar patchclamp structure can be used as a technical platform to monitor cell viability.
In CHAPTER 3 we discuss the various components o f the microchip. The design
aspect of each component including the micropipette, which is the most vital part o f the
microchip, is explained with different schematics. The chapter concludes with a mention
of the various materials and equipment that are required to fabricate the microchip.
A detailed fabrication process for each component o f the microchip is discussed
in CHAPTER 4.
CHAPTER 5 discusses the build up to the real-time viability monitoring
experiments by introducing the experimental setup and the protocol used.
In CHAPTER 6 we discuss the performance o f the patch-clamp microchip. The
ion-channel currents for 12 cells from 4 different cell lines are recorded over a period of
time and simultaneously fluorescence images o f the cell are also recorded. The validity o f
the patch-clamp microchip as a viable technical platform for real-time monitoring o f cell
viability is discussed after comparing the change in seal resistance and the change in
intensity o f the fluorescence images.
In CHAPTER 7 we summarize the patch-clamp microchip project and discuss its
future direction.

CHAPTER 2

PATCH-CLAMP MICROCHIP: RESEARCH BACKGROUND

2.1

Ion-channels

The structure o f a Eukaryotic cell is shown in Figure 2-1. The external membrane
of the cell, called the plasma membrane or cell membrane, plays a crucial role in
maintaining the balance between the intracellular and extracellular environment.
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Figure 2-1: Structure o f a Eukaryotic cell [13].
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The cell membrane is made up o f phospholipids and protein molecules, which are
held together by non-covalent interactions. Specialized trans membrane proteins create
pore like structures on the membrane called ion-channels as shown in Figure 2-2.
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Figure 2-2: Cell membrane with an Ion-Channel [4].

Gating is the process of opening and closing the ion channel; this process
facilitates the transport of ions like Na+, K+, Ca+ or Cl' between the cell and the
surrounding environment. In 1952, Hodgkin and Huxley established that the movement
o f Na+ and K+ in a giant nerve fiber contributed to ionic currents [14]. Hodgkin and
Huxley also established that there were independent ionic pathways for N a+ and K+ flow.
The definite existence o f ion-channels was only demonstrated later, in 1972, by Hladky
and Hayden [15]. Hladky and Hayden studied the change in conductance induced by an
antibiotic gramicidin A. They also observed these channels were permeable to univalent
cations, but completely impermeable to polyvalent anions and cations.
Ion-channels are classified depending on the type o f ion they transport. The
prominent channels are sodium channels, potassium channels, calcium channel, and
chloride channels. The ion-channels open and close in response to a stimulus, the

stimulus could be a change in membrane potential or binding o f a ligand (chemical
messenger). Depending on the stimulus, ion-channels can be classified into three broad
categories: voltage-gated channels, extracellular ligand-gated and intracellular ligandgated as shown in Figure 2-3. The difference in ion concentration between the
intracellular medium (cytoplasm) and the extracellular medium builds up a potential
across the cell membrane; this is called the resting membrane potential. Voltage-gated
channels conduct when there is a change in the membrane potential. Extracellular ligandgated channels conduct in response to ligand molecules binding to the extracellular
domain. Intracellular ligand-gate channels conduct in response to ligand molecules
binding to the intercellular domain.

(a) Resting K*
channel

lb) V oltage-gated
ch annel

K*

(c) L igand-gated
ch an n el

Na*

Id) S ignal-gated
ch an n el

Na*

N a'

Na*

Exterior
Resting
membrane
potential
Cytosol
A lw ays o p e n

—4>

ocJ

| “ t> |

I

SbcJ

OCJ
v
Na+

O pens (transiently)
in resp o n se to c h a n g e
in th e m e m b ra n e
potential

Na*
O p en s (closes) in
re s p o n se to a
specific extracellular
n eu ro tra n sm itte r

•

S *

' ’

N a+

I

'

ifv.K+

O pens (closes) in
re sp o n se to a specific
intracellular m olecule

Figure 2-3: Types o f ion-channel gating mechanisms [16].

Many diseases have been linked to ion-channels [17]. These diseases are usually
caused due to the mutation o f genes in the ion-channels. Research has shown that
mutations in voltage gated Ca2+ channel genes result in migraine headache and some
forms o f epilepsy, while others like long QT syndrome are caused due to the mutation o f
genes in either Na+ or K+ channels. Many o f these inherited ion channel diseases caused
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due to mutation in Na+, K+, Ca2+ and Cl' channels are collectively called channelopathies
[18].

2.2

Drug Discovery

The process o f identifying a chemical compound (drug) that has a therapeutic
effect is tedious and complicated. To find the cure to a disease, it is important first to
understand the disease and the conditions that cause it. Understanding the disease
involves understanding how the genes are affected, how the genes affect the proteins they
encode, how those proteins interact with each other in living cells, how those affected
cells change the specific tissue they are in, and finally how the disease affects the entire
patient’s health. Modem drug-discovery chain can be divided into five basic segments.
They are: target identification and validation, primary screening, secondary screening,
safety screening, and preclinical testing [19].
2.2.1

Target Identification and Validation
Once the underlying cause o f the disease is understood, a target is selected. The

target is a single molecule, either a gene or a protein, which is involved in the disease.
The selection is such that the target can potentially interact and be affected by a drug
molecule. It is important to validate the relevance o f the target to the disease. It is
possible that the target shows a lot o f promise to begin with, but it could eventually lead
to a dead end.
2.2.2

Primary Screening
There are thousands o f molecules known to pharmaceutical companies today.

Primary screening involves exposing the target to different molecules. A specific
modulation is expected to occur in the target upon exposure to these molecules. The

8
screening data is then examined to find the molecules that cause the desired modulation;
these molecules are identified as lead compounds.
2.2.3

Secondary Screening
Primary screening helps construct focused libraries, which are then optimized

during the secondary screening. For example, the structure o f a molecule can be changed
in a way such that it does not react with any other chemical pathways in the body, thus
reducing the potential for side effects.
2.2.4

Safety Screening
Every lead compound is tested for safety. These tests target the pharmacokinetics,

or absorption, distribution, metabolism, excretion, and toxicological properties o f the
lead.
2.2.5

Preclinical Testing
This stage involves a large number o f in vitro and in vivo tests to narrow down the

candidate drugs, which will be studied in the clinical trials. In vitro tests are conducted in
the lab and carried out in beakers and test tubes. In vivo tests are conducted on animal
models and living cells. The data from these tests shows the efficacy o f the drug and its
safety profile.

2.3

Ion-channel Assays

The process to find candidate drugs that can cure an ion-channel related disease is
the same as discussed in Section 1.2. There are several types o f popular standard ionchannel assay technologies, and new emerging technologies have been reported every
year. The most popular ion-channel assay technologies are: Patch-clamping,
Fluorescence-based methods, Flux assays, and Binding assays [20].
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2.3.1

Patch-clamping
The patch-clamp technique involves placing a pipette (tip o f the pipette is a few

microns in diameter) with electrolytic solution against the cell membrane o f a living cell
and applying a small amount o f suction. This suction forms a tight electrical seal between
the cell membrane and the pipette usually in the order o f giga-ohms. An Ag/AgCl
electrode is then inserted into the pipette such that it makes contact with the electrolyte in
the pipette. The ionic current between the electrolyte and the cell is sensed by this
electrode and fed to an amplifier, which analyzes the conductance and kinetics associated
with the ion-channels. A simple patch-clamp configuration is shown in Figure 2-4. The
patch-clamp technique proves to be a great tool with high potential in the research o f
neuroscience and electrophysiology for its ability to measure functions directly like
gating, permeability, voltage sensing, and selectivity o f ion-channels.

Electrode

Micropipette

Cell Membrane
Figure 2-4: Simple patch-clamp configuration [21]

Na+ channel
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2.3.2

Fluorescence-based Methods
These techniques involve loading fluorescent dyes into the cytosol or cell

membrane. The flow o f ions between the

intracellular and extracellular medium can lead

to a change in the membrane potential or can change theion concentration in one o f the
mediums. The fluorescent dye loaded in the cell membrane is sensitive to these changes
and, instead o f measuring the ionic current directly, the change in fluorescence signals is
measured. Optical techniques like total internal reflection fluorescence (TIFR) have been
used to measure single-channel Ca2+ flux [22],
2.3.3

Flux Assays
This assay involves utilizing radioactive isotopes to trace the cellular influx or

efflux o f specific ions. The cells that contain the ion-channel o f interest are incubated in a
buffer containing radioactive isotopes for several hours and then washed. The cells are
then incubated in a solution o f agonist; this allows the efflux o f the isotope. Finally, the
radioactive counting o f the cells and supernatant is performed [23].
2.3.4

Binding Assays
Binding assay detects the binding o f a compound (ligand) to an ion-channel. This

assay does not examine how the binding will alter the function o f the channel; hence, it is
not considered a functional assay. A typical binding assay involves using a radioisotope
to label a known ligand for the ion-channel.

2.4

Patch-clamp Technique

The invention o f the patch-clamp technique is accredited to Erwin Neher and Bert
Sakmann, who in 1976 reported a technique to record single-channel currents from the
membrane of denervated frog muscle fiber [24]. It was the first device that measured the
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flow o f the current through a single ion-channel. Their technique involved placing a tiny
glass pipette against a living cell membrane and applying a small amount o f suction to
form a tight seal between the pipette and cell membrane. This electrical seal had a
resistance o f order o f 50 MQ [25]. Neher and Sakmann soon realized the source o f noise
in the measured single ion-channel current was due to the leak in the seal between the cell
membrane and the pipette. In 1981, a group o f researchers including Neher and Sakmann
reported an improved patch-clamp technique. This technique could achieve a “gigaseal”,
an electrical seal in the order o f 109-10n ohms, and thus reduce the noise in the recorded
channel current by an order o f magnitude [26]. Such was the impact o f this discovery,
that in 1991, Erwin Neher and Bert Sakmann were jointly awarded the Nobel Prize in
Physiology or Medicine for their discoveries concerning the function o f single ionchannels in the cells. Today, the patch-clamp is the most widely used technique to study
the electrophysiological properties o f biological membranes and widely accepted as a
gold standard in electrophysiology.
2.4.1

Principle o f Operation
An electrical model for a cell is shown in Figure 2-5. The membrane represents a

capacitance Cm\ the conductance o f each ion-channel

(g N a , g c a , g K i, gK 2,

gi) present in the

cell is a variable depending on whether the channel is open or closed. The current through
a single ion-channel can then be represented by a variable conductance in a series with
the reverse potential o f the channel. The membrane potential E depends on the ionchannel currents 7, according to [27]

Eq. 2-1
j
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The current through an individual ion-channel can then be modeled as
lj =

9j { E -

Eq. 2-2

Ej).

Cell interior
INa

ICa

gNa

gCa

Cm
ENa

ECa

EK

Extracellular medium
Figure 2-5: Electrical model o f a cell. The sodium, calcium and potassium ionchannels are modeled as a variable conductance depending upon whether
they are open or closed. The cell membrane is modeled as a capacitor; the
reverse potential o f each channel is modeled as a voltage source.

The patch-clamp technique involves placing a pipette (tip o f the pipette is a few
microns in diameter) with an electrolytic solution against a living cell membrane and
applying a small amount o f suction. This suction forms a tight electrical gigaseal between
the cell membrane and the pipette. An Ag/AgCl electrode is then inserted in the pipette
such that it makes contact with the electrolyte in the pipette and a voltage pulse is
applied. The ion-channel current now balances the injected current Imj due to the pulse.
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The relationship between the injected current lm} and the ion-channel current is
dE S T
Cm~ d t+ Z u Ij = Iin i '
j

Eq. 2-3

If E is constant, the injected current is equal to the ion-channel current, and
therefore is a direct measure o f the ion-channel current.
2.4.2

Patch-clamp Configurations
Researchers have used different configurations o f the basic patch-clamp technique

to achieve their goals. The commonly used configurations are: Cell-attached, Inside-out,
Whole-cell, Outside-out, and Perforated.
2.4.2.1

Cell-attached Configuration
This is the simplest configuration that is achieved as soon as the pipette is placed

against the cell membrane and a small amount o f suction is applied to form an electrical
seal between the pipette and the cell membrane. The advantage o f this configuration is
that it can measure the current through a single ion-channel in that patch o f the
membrane. Since the electrical seal resistance is very high, this method requires very
sensitive and low-noise electronics to record the correct current.
2.4.2.2

Inside-out Configuration
This configuration is achieved with a two-step process. First, an electrical seal

between the pipette and the cell membrane is achieved by placing the pipette against the
cell membrane and a small amount o f suction is applied (cell-attached configuration).
Step two is to withdraw the pipette quickly so that it tears off the membrane patch. This
configuration is preferred when the objective is to study the effect o f environmental
changes on the inside o f the ion channels.
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2.4.2.3

Whole-cell Configuration
This configuration is achieved with a two-step process. First, an electrical seal

between the pipette and the cell membrane is achieved by placing the pipette against the
cell membrane and a small amount of suction is applied (cell-attached configuration).
Step two is to apply pulses o f suction or voltage to rupture the patch membrane. Unlike
the inside-out configuration, the cell is still attached to the pipette in the whole-cell
configuration. As compared to the cell-attached configuration, the larger opening at the
tip o f the pipette is now an advantage since the resistance is lowered and there is better
electrical access to the inside o f the cell. The disadvantage though is that the soluble
content o f the cell will be quickly replaced by the solution in the pipette, and hence, the
experiment has to be concluded within a shorter time frame.
2.4.2.4

Outside-out Configuration
To achieve the outside-out configuration, first the whole-cell patch is achieved,

and then the pipette is withdrawn from the cell so that the patch is tom off the cell. The
patch then reforms itself in the form o f a ball at the tip o f the pipette. This configuration
is useful when the aim is to study the ion-channel function when it is not in the living cell
environment.
2.4.2.5

Perforated Configuration
The perforated configuration tries to bridge the cell-attached and whole-cell

configuration. Starting with the cell-attached configuration, special molecules are
introduced in the pipette that is capable o f perforating the patch membrane. Therefore,
unlike the whole-cell configuration, the content o f the cell will not be diluted quickly.
The time needed to perforate the patch membrane may vary; hence, this method may not
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be helpful if the experiment is to be completed in a limited time frame. Another problem
that could arise is the chance that the process o f patch perforation might cause rupture,
and this will end up as a whole-cell configuration instead. The different patch-clamp
configurations are shown in Figure 2-6.
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Figure 2-6: Patch-clamp configurations [28].

2.5

Planar Patch-clamp

The patch-clamp configurations are widely popular in research labs because they
provide researchers the flexibility to study various ion-channel functions. However, in its
simplest form, there are certain aspects o f the conventional patch-clamp technique that
limit the uses o f this technology to research work in the laboratory. It takes a highly
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skilled and experienced operator to apply the correct amount o f suction to achieve the
whole-cell configuration, and to perform simultaneous other activities like replacing the
solution inside the pipette and recording the current while observing the cell under a
microscope. The labor involved and the very low throughput make the conventional
patch-clamp unpopular and unrealistic for wide use in the industry.
There is great interest in developing an automated version o f the patch-clamp that
can perform recordings o f thousands o f cells in parallel and facilitate the screening
process involved in the drug-discovery cycle. In 2003, a company called Flyion used
their existing Flip-the-tip technology and launched a fully automated, robot-controlled
system called Flyscreen 8500 to replace the human operator in the conventional patchclamp technique [29]. However, the technology reported by Flyion still involved using a
glass pipette and throughput was still less than what the industry demanded.
The idea o f having a chip that can hold several thousand micropipettes and allows
parallel recordings is very intriguing, and since the 1990’s there have been several
attempts to develop such a chip. Where the conventional techniques exclusively made use
o f a glass pipette, the modem approach makes use o f different materials. In the first
attempt to fabricate a patch-clamp chip, both optical lithography and low-energy
electron-beam lithography were used to define patterns on a silicon wafer. We then
etched these patterns using reactive ion etching and wet etching to achieve orifices that
were as small as 50 nm in diameter [30]. Even though the processes for fabricating micro
and nano-structures out o f silicon are well established, silicon does suffer from a few
problems. A high-density of charge in the silicon can give rise to a parasitic current,
which is undesirable when dealing with very low ionic currents, and it is also difficult to

17

form a gigaseal when using a silicon-based pipette [31]. Glass offers a good alternative to
silicon, especially when optical methods utilizing fluorescence are used to study ionchannel functions. The seal quality is also much better between a glass pipette and a cell
membrane. The conventional wet etching process on glass yields structures that are not
perfectly circular and produce poor seal quality. Fertig et al. reported an ion-track etching
technique that could produce a smooth aperture with a diameter o f 1pm or smaller [32],
[33]. The basic structure o f the planar patch-clamp device is shown in Figure 2-7.

Figure 2-7: Basic structure o f a planar patch-clamp device. A) Top view o f the planar
aperture on a glass chip. B) Cells are suspended and then suction is
applied. C) A cell forming a seal with the aperture [27], [33].

One o f the challenges faced when using conventional or modem day planar patchclamp devices is the ability to reuse the micropipette. Experiments have confirmed that
once the initial gigaseal between the pipette and the cell membrane is achieved, it is very
difficult to reproduce another gigaseal for the subsequent capture o f cells. The problem is
attributed to the debris left over by the initial gigaseal which is very difficult to remove,
thus hindering the subsequent formation o f another gigaseal [27]. The idea o f a
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disposable pipette is very attractive in scenarios where thousands o f precision recordings
are needed.
Photolithography has been a dominant technology in fabricating micro patterns
and structures, but one has little to no control over the chemistry o f these structures,
especially when these patterns and structures are to be fabricated out o f materials made of
complex functional groups. A lot o f non-lithographic techniques have been used to
fabricate micro and nano scale structures that can be specifically used in the field o f
chemistry, biochemistry and biology. A technique that involves the use o f a patterned
elastomer as a mask, stamp, or mold is called Soft Lithography [34]. Soft lithography
produces a micro or nano scale structure by replica molding, embossing or using selfassembly as contact printing. Polydimethysiloxane (PDMS) is a very attractive material
for soft lithography; it can be easily molded and hence offers great flexibility to make
complex micro and nano scale patterns. Patch-clamp devices with micrometer scale
apertures have been fabricated using PDMS [35], [36]. PDMS has also become one o f the
most preferred materials for fabricating microfluidic channels on patch-clamp chips.
Integrating microfluidic channels on the chip helps facilitate the transport o f cells to the
pipette site.

2.6

Cell Viability and Cytotoxicity

Cell viability deals with determining whether a cell is living or dead. As
mentioned in Section 2.2.4, the toxicological property o f the lead compound is important
for successful drug discovery. The cytotoxicity assays performed during safety screening
involves exposing a known number o f sample cells to the lead compound, and then
counting the surviving cells. The cell viability and cytotoxicity assays are based on
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various cell functions such as: enzyme activity, cell membrane permeability, cell
adherence, ATP production, co-enzyme production, and nucleotide uptake activity [37].
The commonly used techniques are colorimetric or fluorometric. The colorimetric
method uses salts that change color depending on a particular cell function. For example,
the salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) measures
the activity o f dehydrogenase enzymes. MTT is a pale yellow substrate, but when added
to living cells, the tetrazolium ring o f MTT is cleaved in the mitochondria o f the living
cells that produce a dark blue formazan. It is then easy to read the living cells with a
scanning multi well spectrophotometer [38]. The fluorometric method uses dyes and the
intensity o f these dyes changes according to some particular cell function. For example,
Calcein-AM can pass through the cell membrane and gets hydrolyzed by the esterase in
the cell to be converted to calcein, a fluorescence dye. The total esterase activity depends
on the total number o f viable cells; hence, the fluorescence intensity is directly correlated
to the number o f living cells [39].

CHAPTER 3

PATCH-CLAMP MICROCHIP: DESIGN, MATERIALS, AND
EQUIPMENT NEEDED FOR FABRICATION
3.1

Patch-clamp Microchip Design

A schematic o f the patch-clamp microchip used for this research is shown in
Figure 3-1. This microchip comprises o f a micropipette, a pipette extension, and a fluidic
channel. Air bubble (AB) actuators are incorporated to guide the cell to the site o f the
pipette.

Cell sorter

Air bubble^
(AB) actuator
Figure 3-1: Schematic o f the patch-clamp device used. The chip has actuators for
selecting and positioning the cells.
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3.1.1

Input and Output Wells
The cells to be tested are flown into the device via the input well. The input well

is the interface between the device and the syringe containing the cells to be tested. The
cells flow through the fluidic channel and the unused cells are collected at the output
well.
3.1.2

Fluidic Channel Design
The fluidic channel between the input and output wells is designed to carry the

cells from the input well to the site o f the pipette for recording the currents.
3.1.3

Air-bubble Actuators
The air-bubble actuators allow for selecting the cell and guiding it to the pipette

site. To achieve cell selection and guidance, the device makes use o f integrated airbubble actuators as shown in Figure 3-2 and Figure 3-3 [40]. These actuators consist o f
chromium micro heaters enclosed inside the actuator well. An external voltage creates
joule heating in the micro heaters that heats the air inside the chamber to generate the airbubbles. The air bubbles then change the path o f the cell and guide it to the pipette site. A
combination o f actuators is used to achieve cell selection and guidance.

input well
Ag/AgCI e le c tro d e s?

cell sorting function

output well 5 mm
i . _____ ______ ____________ ___

cell positioning function

Figure 3-2: Close-up view o f the cell sorting and positioning actuators [40],
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(a)

(b)
Figure 3-3: Cell sorting mechanism. A) The target cell and the target direction is
identified B) Applying a voltage pulse to the actuator on the left, deflects
the cell into the target direction [40].

3.1.4

Micropipette Design
The micropipette is the most important feature o f the device as the aperture

defines the quality o f the electrical seal. The micropipette orientation and dimension are
the two most important design elements. The desired length o f the micropipette was 15
pm, but the mask for the micropipette was designed to have a length o f 35 pm to
eliminate alignment issues when the mask for the pattern containing the fluidic channel
and the micropipette extension are used. Figure 3-4 shows the micropipette’s position
with respect to the fluidic channel and pipette.
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Output well

Figure 3-4: Schematic top-view o f the device showing the position o f the
micropipette.

3.1.5

Pipette Extension
The micropipette is connected to a well via a channel as shown in Figure 3-4; this

combination is called the pipette extension. To form an electrical seal, the well is
connected to a device that can generate negative pressure. Once the electrical seal is
achieved, the well holds an Ag/AgCl electrode to record the currents. The typical size of
the MDA-MB-231cell is between 10 and 20 pm in diameter. Hence, the width and height
o f the channel has to be greater than the size o f the cells. Except for the micropipette
(height 3 pm), the height o f all the other parts is 50 pm. A 3D model o f the device
showing the close up view of the micropipette is shown in Figure 3-5.
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Fluidic
Channel

Micropipette

Figure 3-5: 3D model o f the device showing the close up view o f the micropipette.
The length, width, and height o f the micropipette are 15 pm, 3 pm, and 3
pm, respectively. The height o f the fluidic channel is 50 pm.

3.2

Materials and Equipment

The materials and equipment needed for this project are divided based on the
research cycle: fabrication o f the patch-clamp microchip, and using the patch-clamp
microchip to monitor cell viability.
3.2.1

Materials used for Fabricating the Patch-clamp Microchip
The patch-clamp microchip was fabricated using photolithography techniques.

The following is a list o f wafer cleaning chemicals, photoresists, photoresist developer,
and other chemicals used to fabricate the device.
3.2.1.1

Microscopic Glass Slide
Microscopic glass slides were purchased from Fisher Scientific.

3.2.1.2

Silicon Wafer
The silicon wafers were purchased from Silicon Valley Microelectronics, Inc.

Some important wafer specifications are: diameter: 100+/-0.5 mm, orientation: <1-00>+/-l°, type/dopant: N/As, resistivity: 0.002-0.004 ohm-cm, and film: 2000 A +/-5%
thermal oxide.
3.2.1.3

Ammonium Hydroxide
Ammonium hydroxide, assay 28-30 w/w% was purchased from Fisher Scientific.

3.2.1.4

Hydrogen Peroxide
Hydrogen peroxide, 30% solution, was purchased from EMD Millipore.

Ammonium hydroxide and hydrogen peroxide were used to clean the organic impurities
on the silicon wafer.
3.2.1.5

Polvdimethvlsiloxane (PDMS)
PDMS was the material o f choice to transfer the device pattern containing pipette,

actuator wells and the fluidic channel. As discussed in Section 2.5, PDMS is a very
attractive material to fabricate chips that are disposable and cost effective. Micro and
nano scale patterns can be easily transferred to PDMS using techniques like replica
molding, embossing, or by using self-assembly as contact printing. We purchased PDMS
(Sylgard® 184 Silicon Elastomer Kit) from DOW Coming Corporation.
3.2.1.6

PDMS Curing Agent
PDMS curing agent (Sylgard® 184 Silicon Elastomer Curing Agent) was

purchased from DOW Coming Corporation.
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3.2.1.7

SU-8 2050
SU-8 2050 is a high contrast, epoxy-based photoresist designed for

micromachining and other microelectronic applications where a thick, chemically and
thermally stable image is desired. SU-8 2050 has excellent imaging characteristics and is
capable o f producing very high aspect ratio structures. SU-8 2050 has very high optical
transmission above 360 nm, which makes it ideally suited for imaging near vertical
sidewalls in very thick films. SU-8 2050 is best suited for permanent applications where
it is imaged, cured and left on the device. There are several patterns (pipette, actuator
wells, input and output wells, and fluidic channel) required on the mold and it is critical
to appreciate the different dimensions needed for them. Figure 3-5 highlights the height
variation needed for the pipette and the rest o f the pattern. SU-8 (negative photoresist) is
a common material used to fabricate molds, but in this case, using SU-8 to fabricate the
pipette mold complicates the process because SU8 has to be coated on the silicon wafer
with two different thicknesses. To simplify the process, the pipette mold was fabricated
out of silicon, while the rest o f the patterns on the mold were fabricated out o f SU-8.
3.2.1.8

SU-8 Developer
The SU-8 developer is used to develop patterns exposed on the SU-8 photoresist.

3.2.1.9

Shipley S1813
Shipley S I813 is a positive photoresist; upon exposure to light, the photoresist

depolymerizes which makes it easy to selectively dissolve the exposed resist faster with
the help o f a developer.
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3.2.1.10

LOR 7B

Lift-off resist, LOR 7B, was purchased from MicroChem. LOR 7B, when used in
conjunction with a photoresist to create a bilayer, can facilitate a high-yield metal lift-off
process.
3.2.1.11

MF-319

MF-319 was purchased from DOW Chemical. MF-319 is used to develop patterns
exposed on Shipley 1813 photoresist; it is also capable o f developing LOR 7B.
3.2.1.12

Remover PG

Remover PG was purchased from MicroChem. Remover PG is a solvent stripper
designed to remove photoresists efficiently and completely. It was also used in the lift-off
process as a lift-off solvent.
3.2.2

Materials Needed for Monitoring Cell Viability

3.2.2.1

Calee in A M
Calcein is a fluorescent dye and Calcein AM is the acetomethoxy derivate o f

calcein. Calcein AM can be transported into live cells through the cellular membrane,
which makes it useful for testing the cells’ viability and for short-term labeling o f cells.
3.2.2.2

Propidium Iodide
Propidium iodide is a fluorescent molecule, which cannot permeate into living

cells and is generally used for identifying dead cells in a population.
3.2.2.3

Cell Lines and Culture
Four human breast cancer cell lines have been used for these studies, which

includes MDA-MB231, MDA- MB231-brain metastatic subline (abbreviated as MB231BR), MB231-BR over-expressing HER2 gene (MB231-BR-HER2), and MB231-BR-
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vector control for the HER2 (M B231-BR-vector). The cells were transfected to
overexpress HER2 as described by Palmieri et al. [41]. The MB231-BR, MB231-BRHER2, and MB231- BR-vector cell lines were kindly provided by Dr. Patricia Steeg
(Women’s Cancers Section, Laboratory o f Molecular Pharmacology, National Cancer
Institute, National Institutes o f Health, Bethesda, MD). The cells were maintained in
Dulbecco’s modified Eagle Medium (DMEM, Invitrogen) supplemented with 10% fetal
bovine serum (FBS, Invitrogen) and 1% penicillin treptomycin solution (Invitrogen).
3.2.3

Equipment Needed for Fabrication

3.2.3.1

Inductively Coupled Plasma Etcher
Inductively coupled plasma etcher (Alcatel 60IE) was used to etch the

micropipette pattern in the silicon wafer.
3.2.3.2

Oxveen Plasma Etcher
A low powered reactive ion etcher (Technics Micro-RIE, Series 800) was used to

generate oxygen plasma to bind the PDMS mold on the silicon wafer.
3.2.3.3

Hot Plate
The hot plate was used to dry the wafer after the initial cleaning step. The soft-

bake required for the photoresist and LOR 7B was also done on the hot plate.
3.2.3.4

Spin Coater
The spin coater, manufactured by Cost Effective Equipment, was used to coat the

uniform thickness o f the photoresist and LOR 7B on the wafer.
3.2.3.5

UVLight Source andM askA liener
SUSS MicroTec mask aligner was used to align the mask and the wafer; the wafer

was then exposed to a UV light source.
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E-beam Evaporator

3.2.3.6

The E-beam evaporator from CHA industry was used to deposit chromium (Cr)
on the micro heaters’ pattern.
Optical Microscope

3.2.3.7

An optical microscope (Olympus Vannox AHMT3) was used during various
stages o f fabrication to inspect the patterns on the wafer.
3.2.4

Equipment Needed for Monitoring Cell Viability

3.2.4.1

Svrinee Pump
A syringe pump (kd Scientific) was used to pump the cells into the fluidic

channel.
Biopsy Punch

3.2.4.2

We used 1.5 mm Biopsy punch (Miltex, Inc) to punch holes into the PDMS mold
at the sites o f input and output wells.
Tubes

3.2.4.3

Tubes were used to connect the syringe pump to the input well to allow the
transport o f cells.
Patch-clamp Amplifier

3.2.4.4

To measure the ion-channel currents, we utilized a patch-clamp amplifier (Dagan
Corporation, PC-ONE).
D isital Oscilloscope

3.2.4.5

We record the ion-channel currents using a digital oscilloscope (Tektronix TDS
1012B).
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3.2.4.6

Fluorescence Microscope
A fluorescence microscope (Olympus 1X51) was used to capture the fluorescent

signals from the Calcein AM and Propidium Iodide.

CHAPTER 4

PATCH-CLAMP MICROCHIP: FABRICATION
The entire microchip fabrication can be divided in four major steps: 1) Fabricating
the mold on a silicon wafer; the mold contains the patterns for the pipette, actuator wells,
input and output wells, and the fluidic channel 2) Transferring the patterns on the mold to
PDMS 3) Fabricating air-bubble actuators on a glass substrate 4) Binding the PDMS
replica with the air-bubble actuators on the glass substrate.

4.1

Mold Fabrication

The mold contains the patterns for the pipette, actuator wells, input and output
wells, and the fluidic channel.
4.1.1

Pipette Mold
As mentioned earlier, the pipette is the most critical part o f the device due to the

specific dimensions needed. The traditional top-down approach was used to fabricate the
pipette out o f silicon. First, the p-type silicon wafer (<100>) was cleaned using 1:1:5
solutions o f the ammonium hydroxide, hydrogen peroxide and deionized water at 80° C
for 15 minutes. The wafer was then dried on a hot plate at 100°C for 10 minutes. A one
micron thick layer o f Shipley 1813 photo resist was uniformly coated on the wafer using
a spin coater (Brewer Science, Model 100). The wafer was then baked on a hot plate at
100° C for 90 s and cooled at room temperature for five minutes. The pipette mask was
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mounted on a SUSS MicroTec mask aligner, and the wafer was loaded in the machine
and exposed. The data sheet for photo resist 1813 specifies the exposure time and the
energy required for a good transfer o f pattern. In most cases, the exposure time and
energy required varies according to the life o f the light source. For this machine, the
exposure time between 6-10 s and a power o f 1000 watts has always proved sufficient to
successfully transfer the pattern onto the wafer. The exposed wafer was developed in
M F319 for around 90 s, rinsed with DI water, and baked on a hot plate at 100° C for 60 s.
To etch the pattern, the wafer was loaded in an inductively coupled plasma etcher
(Alcatel 601E). The deep reactive ion etching (DRIE) process was used; each cycle is
composed o f the etching step followed by the passivation step. First, the silicon was
etched by flowing SF6 gas at a rate o f 100 seem (standard cubic centimeter per minute)
for 4 s and then C4F 8 was flown at a rate o f 70 seem for 6 s to protect the sidewalls. The
RF power was maintained at 800 W and the plate voltage was maintained at 35 V for the
etching step. It took around 15 cycles to etch 3 pm o f silicon pipette pattern. After the
etching process, the photoresist on the wafer was cleaned with acetone followed by an
IPA and DI water rinse. The final pipette dimensions are: 35 pm, 3 pm, and 3 pm for
length, width, and height, respectively. Figure 4-1 shows the pattern generated in the
plane containing the cross-section o f the pipette extension (input well and the channel
connecting the pipette), and the fluidic channel.
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Spin coat the positive
photo resist

Expose the wafer to
Micro-pipette mask

Silicon
Wafer

Develop the exposed
wafer

S1813

Perform Deep
Reactive Ion Etching

□

Micro-pipette
mask

Final structure:
Micro-pipette die
Figure 4-1: Process flow for fabricating the pipette mold on the silicon wafer.

4.1.2

Mold for Actuator Wells. Input and Output Wells, and Fluidic Channel
A standard clean was performed on the silicon wafer with the pipette mold to

remove organic waste deposited during the etching step. The required thickness for this
mold is 50 pm as discussed in Section 3.1. The data sheet for SU-8 2050 specifies the
resist to be spun at 3000 rpm to achieve 50 pm thickness [42]. The deposition was
followed by a soft bake at 95° C for 6 minutes and then the wafer was cooled at room
temperature for 10 minutes to remove any unwanted wrinkles. The wafer was then
aligned with the mask mounted on the mask aligner and exposed to a light source o f 350400 nm and energy o f 150-215 mJ/cm2. A post exposure bake at 95° C for six minutes
was performed before immersing the wafer in the SU-8 developer for 5-7 minutes to
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develop the patterns on the wafer. Finally, the wafer was rinsed with IPA and DI water
and dried with nitrogen. The process flow shown in Figure 4-2 shows the patterns
generated in the plane containing the cross-section o f the pipette extension (input well
and the channel connecting the pipette), and the fluidic channel. It is now easy to
appreciate why the length o f the pipette in the pipette mask is 35 pm and not 15 pm,
which is what is desired. For a pipette length o f 15-pm, any alignment error due to the
machine or the operator can create a scenario where the pipette is either not connected to
the pipette extension or the fluidic channel. The longer length o f the pipette ensures there
is no break along the path containing the pipette extension, pipette and the fluidic
channel. A 3D model o f the SU-8 mold is shown in Figure 4-3.

Spin coat negative photo
resist

Expose the wafer to the
fluidic m ask

Silicon wafer

Develop the exposed
wafer

SU-8 2050

Perform hard bake

Fluidic m ask

Final structure:
SU-8 die

Figure 4-2: Process flow showing the pattern generated in the plane containing the
cross-section o f the pipette extension and the fluidic channel.
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Input well

Micropipette

Output well

Figure 4-3: 3D model o f the SU-8 mold. The mold for input and output well, fluidic
channel, air-bubble actuators, and Ag/AgCl electrode is made out o f SU8 (red color). The mold for the micropipette is made out o f silicon (blue
color)

4.2

PDMS Replica

The curing agent was added to the PDMS base 1:10 ratio and stirred well, which
caused air, visible as air bubbles, to be trapped in the mixture. The mixture was then
placed in a degassing chamber and the pressure was gradually reduced to less than 200
Torr for 30 minutes. This mixture was then poured over the mold and baked in a
conventional oven for three hours at 70° C. After removing the mold from the oven, the
PDMS was carefully peeled off the mold and the replica was obtained.
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4.3

Air-Bubble Actuators

The glass slide was first cleaned in a solution containing 1:1:5 o f ammonium
hydroxide, hydrogen peroxide and DI water, respectively, at 80° C for 15 minutes. A 700
nm thick layer o f LOR 7B was deposited on the glass slide by spinning the slide in the
coater at 3000 rpm for 45 s. The glass slide was soft baked on the hot plate at 180° C for
three minutes and subsequently cooled at room temperature for five minutes. The soft
bake temperature and time are critical as they have a direct effect on the undercut rate
[43].
Next, a one-micron thick layer o f S 1813 resist was deposited on the glass slide
using a spin-coater spinning at 3000 rpm for 50 s. The glass slide was then soft baked on
a hot plate at 100° C for 90 s followed by cooling it at room temperature for five minutes.
The micro heater pattern was then transferred on the glass slide using the mask aligner
and immersed in M F319 solution for 60 s to develop the pattern. Following a DI water
rinse, the undercut pattern was investigated under the microscope continuously. A good
undercut ensures easy lift off; if the undercut was not prominent, the slide was immersed
back into the developer solution and reinvestigated for the undercut.
After achieving a good undercut, a 200 nm thick layer o f chrome was evaporated
on the slide. The slide was then immersed in a bath o f Remover PG solution maintained
at 60° C for three hours. After three hours, if the resist stack was not lifted off completely,
the Remover PG bath was changed and the slide was re-immersed for additional time
until the entire resist stack was completely removed. Finally, the glass slide was cleaned
with IPA and DI water. The complete fabrication process for the air-bubble actuator is
shown in Figure 4-4.
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□
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Final structure:
M icro-heaters on g la ss slide

Figure 4-4: Process flow for fabricating the air-bubble actuators.

4.4

Binding PDMS Replica with the Air-Bubble Actuators

To bond the PDMS replica with the glass slide, the PDMS replica was treated
with oxygen plasma (35 seem, 60 W, 10 s) and aligned on the glass slide containing the
micro-heaters.

CHAPTERS

PATCH-CLAMP MICROCHIP: EXPERIMENTAL SETUP AND
PROTOCOL

5.1

Experimental Setup

The objective o f the experiment is to establish that the fabricated planar patchclamp microchip is a capable alternative to measure cell viability. The experiments are
set up in a manner such that both fluorescence imaging and ion-channel currents can be
recorded simultaneously. The fluorescence images are recorded with an Olympus
inverted fluorescent microscope (Olympus, Inc.), while the ion-channel current is
recorded by a combination o f a patch-clamp amplifier (Dagan Corporation, PC-ONE) and
a digital oscilloscope (Tektronix TDS 1012B). It is very important to note this in order to
minimize or even eliminate the EM interference. Ideally, patch-clamp recordings are
performed in a Faraday cage to minimize or even eliminate the electromagnetic (EM)
interference. Proper electrical shielding and grounding practice is observed to reduce or
eliminate the noise. The cells are pumped into the input well o f the device using a syringe
pump. The microchip with assembled Ag/AgCl electrodes and tube connections is shown
in Figure 5-1.
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Figure 5-1: Fabricated microchip with assembled Ag/AgCl electrodes and tube
connection at input well for cell flow.

5.2

Experiment Protocol

The cells were stored in the DMEM buffer; hence, it was important to record the
resistance o f the device with only the buffer flowing through it. The first step of the
experiment was to measure the open pipette resistance. To measure this resistance, the
DMEM buffer without the cells was flown in the device and then 20 mV, 40 Hz square
wave pulse was applied, and the recorded ion-channel current was used to calculate the
seal resistance. Next, the DMEM buffer containing cells was pumped into the input well
of the device using the syringe pump. The flow o f the cells was observed under the
microscope and the cell sorting and positioning mechanism was used to guide the cell to
the site of the pipette. Negative pressure was then applied to form the electrical seal
between the cell and the pipette. Following the cell capture, a 20 mV, 40 Hz square wave
pulse was applied to the Ag/AgCl electrode. The ion-channel current and the
fluorescence image o f the captured cell were recorded simultaneously.

CHAPTER 6

PATCH-CLAMP MICROCHIP: RESULTS AND DISCUSSION

6.1

Ion-channel Current and Seal Resistance of Cell

An optical image o f a captured cell by the micropipette is shown in Figure 6-1. To
record the ion-channel current, a square-wave voltage pulse o f 20 mV, 40 Hz is applied.
The recorded ion-channel current through the device over a period o f time is shown in
Figure 6-2. As expected, under the open pipette condition, the current through the device
is higher, and the calculated seal resistance is ~ 4 MO. Once the cell is captured, the seal
between the cell membrane and the pipette offers a high-resistance. The current through
the device is now a combination o f the ion-channel current and the leakage current
through the seal, with the ion-channel current being the dominant source. The curve T = 0
minute corresponds to the first ion-channel current recorded after the cell is captured. At
this instance the cell has the highest viability, and hence, the lowest ion-channel current
o f -280 pA and largest seal resistance o f -22.0 MO. As mentioned in Section 2.6, the cell
membrane permeability is an indicator o f cell viability. Even though the buffer surrounds
the cell, over a period of time, the cell will lose its viability and, as the cell starts to die,
the ion-channel current increases. The recording at T = 30 minutes shows that the ionchannel current has increased and the corresponding seal resistance has decreased from
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22.0 MQ to 6.5 MD. Eventually after 2 hours the cell is dead and the current is back to
the level o f open pipette and seal resistance is ~ 4 MQ.

Figure 6-1: Close up view o f captured cell [12].
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Figure 6-2: Current through the device over the test period. The current is in response
to a 20 mV, 40 Hz square wave pulse [12].

6.2

Fluorescence Images of Cell

As mentioned earlier, the ion-channel currents and the fluorescence images o f the
cell were simultaneously recorded. Figure 6-3 shows the representative fluorescence
images o f the captured cell. As expected, immediately after its capture, the living cell has
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brighter green fluorescence due to the fact that calcein AM can permeate into living cells
through the cellular membrane. Propidium iodide (PI), however, cannot permeate into
living cells and hence the cell image shows a dimmer red fluorescence. After 120 minutes
the cell loses its viability, which reverses the intensity o f the fluorescence. PI now
permeates into the dead cell and therefore the cell image shows brighter red fluorescence,
while the green fluorescence, due to Calcein AM, grows significantly dimmer.

t 0 minute

t O minute

^ L iv e to dead cell
t~ 120 m i n u t e s ^ B t - 1 20 minute?,

Figure 6-3: Fluorescence images o f the cell, the green fluorescence is due to Calcein
AM and red fluorescence is due to PI [12].

6.3

Comparing the Seal Resistance and Fluorescence Intensity

To validate the viability o f this platform, the seal resistance o f the device was
compared with the recorded PI fluorescence images o f the cell. In Figure 6-4, the blue
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curve represents the variation in seal resistance o f the device over a period o f time while
the red curve represents the variation in PI fluorescence intensity. At T = 0, the cell is
alive and the recorded seal resistance is ~ 22 M£i, while the recorded intensity o f the PI
fluorescence is low. At T = 120 minutes, the cell is dead and the recorded seal resistance
has decreased to ~ 4 MQ, while the recorded intensity o f PI fluorescence has increased
significantly.
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Figure 6-4: Representative measured seal resistance o f the captured cell and
corresponding PI fluorescence intensity. Inset at T = 0 is the PI
fluorescence image o f the live cell (immediately after capture) and inset at
T = 120 minutes is the PI fluorescence image o f the dead cell [12].

In order to obtain systematic experimental results, about 12 cells from each cell
line (cell line 1 MB231; cell line 2 M B231-BR-vector; cell line 3 MB231-BR-HER 2;
cell line 4 MB231-BR) were tested. It took about two to four hours to complete the
experiments for each cell. Representative experimental results for five cells from each
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cell line are plotted in Figure 6-5. The recorded ion-current values show a consistent
decrease in the seal resistance as the cell loses its viability, until finally the seal resistance
reaches the value o f open pipette. Based on these results, it is very clear that the change
in seal resistance correlates very well with the health (alive or dead) o f the cell.
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Figure 6-5: Summary o f seal resistance change for four cell lines, a change in the seal
resistance shows similar trend, a) cell line 1 MB231; b) cell line 2 MB231BR-vector; c) cell line 3 MB231-BR-HER 2; d) cell line 4 MB231-BR [12].

6.4

Summary

In this chapter we discussed the performance o f the patch-clamp microchip. The
ion-channel currents for 12 cells from each cell line (cell line 1 MB231; cell line 2
MB231-BR-vector; cell line 3 MB231-BR-HER 2; cell line 4 MB231-BR) were recorded
over a period o f time and simultaneously fluorescence images o f the cell were also
recorded. The validity o f the patch-clamp microchip as a viable technical platform for
real-time monitoring o f cell viability was established after comparing the change in seal
resistance and the change in intensity o f fluorescence images.

CHAPTER 7

PATCH-CLAMP MICROCHIP: CONCLUSIONS AND FUTURE
WORK

7.1

Conclusions

Systematic measurements o f the cell’s electrical properties (e.g., ion channel
current and seal resistance) were performed using PC microchips. All o f the experimental
results indicate that PC microchips provide a viable technical platform for monitoring cell
viability in real time. This was confirmed by simultaneously carrying out the experiments
using the conventional technology i.e. monitoring the changes o f the fluorescence images
o f cells. Therefore, given its simplicity o f direct electrical measurement o f cells without
fluorescence labeling, the technical platform based on PC microchips may pave a way for
high efficiency drug effect analysis on cancer cells given their direct electrical
measurements on cells and the fluorescence dye labeling o f the cells can be completely
avoided.

7.2

Future Work

This technique can quantify the ion current and seal resistance o f single cells,
thereby providing the quantified information for specific types o f cells, which would
greatly benefit ion-channel based drug discovery [44], [45].
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Future work will focus on the real-time monitoring o f controlled drug effects on
cells using this platform. This will be achieved by integrating a controlled drug release
microfluidic platform with PC microchips.

CHAPTER 8

FET BASED BIOSENSOR: INTRODUCTION
Proteins, including enzymes, antibodies and some hormones, are common targets
in clinical diagnosis. The ability o f an antibody to identify and form complexes with
corresponding antigen is highly specific and forms the basis o f immunoassay techniques.
ELISA is the most commonly used conventional enzyme immunoassay technique but has
several limitations. To begin with, these techniques require a laboratory setup with a
highly qualified technician who can execute the complex multistage process while
analyzing the results. The analysis can take several hours, making it unsuitable for
applications where quick determination o f analyte is required. Smart biochips made of
novel materials and structures are now capable o f performing some o f the basic in vitro
diagnostic tests involved in immunoassays. The discovery o f novel materials like carbon
nanotube (CNT) has opened up new opportunities to engineer biosensors made from
individual CNT that are ideally capable of detecting biomolecules on a molecular level.
Since every atom in a CNT is a surface atom, they form an ideal class o f ID
nanostructures that could exhibit ideal sensitivity at a single molecular level [46]. The
transfer o f charge from one electrode to another is a very important aspect in any
electrochemical reaction, and it has been shown that CNTs promote electron-transfer
reactions of proteins [47]. Most o f the modem biosensors have exploited the
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semiconducting nature o f CNT to design a label-free field-effect transistor (FET) based
immunosensor (biosensor that exclusively monitors the antibody-antigen interaction).
Even though biosensors made out o f a single CNT are ideally capable o f detecting a
single molecule, the biggest hurdle in using CNT for biosensors is the process involved in
assembling this nanostructure into the sensor. For sensors based on ID structure like
CNT, there are huge variations in the device’s characteristics. Due to these variations, it
is very important to calibrate each sensor before use. It is a major challenge to develop a
reusable CNT based sensor that can be calibrated easily before deployment in a real-life
scenario.
To avoid the fabrication complexity involved with a single CNT immunosensor,
we have developed an FET based biosensor, in which the channel is fabricated out o f
carbon nanotubes thin film (CNTF). The CNTF channel between the source and drain
electrodes was assembled using electrostatic layer-by-layer assembly (LBL). To
investigate the potential o f the device as an immunosensor, we used the bio-affinity
interaction between Protein A and rabbit IgG to model the antibody-antigen interaction.

8.1

Key Accomplishments of the Project

The key accomplishments o f the project include the fabrication o f the FET device
using LBL assembly and the verification o f the behavior o f the device as a p-type
transistor. To study the antibody-antigen interaction, the bio-affinity interaction between
Protein A and rabbit IgG was used as a model and initial results suggest that the device
can detect IgG concentrations as low as 1 pg/mL.
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8.2

Outline o f FET Based Biosensor Project

In CHAPTER 9 we begin with a discussion on conventional techniques used in
immunoassays, their disadvantages, and make a case for the use o f biosensors. The
various types o f biosensors and the impacts o f nanotechnology on these sensors are
discussed. A detailed study o f carbon nanotube and its application as an electrochemical
sensor is presented, along with a brief discussion on protein immobilization and its
significance. Next, a discussion on the challenges involved in fabricating a sensor made
out o f single CNT and a case for carbon nanotubes thin film (CNTF) is made. Finally, the
fabrication techniques, with a focus on layer-by-layer self-assembly and electrical
properties o f CNTF, are discussed.
In CHAPTER 10 the design aspects of the device are presented, as well as a
mention o f the various materials and equipment required to fabricate the biosensor.
A detailed fabrication process for each component o f the biosensor is discussed in
CHAPTER 11.
CHAPTER 12 begins with an introduction to the experimental setup and the
protocol used, continues with a discussion on the behavior o f the device as a transistor,
and ends with a discussion on the performance o f the device as a biosensor to detect the
bio-affinity interaction between Protein A and rabbit IgG.
In CHAPTER 13 we summarize the FET based biosensor project and discuss its
future direction.

CHAPTER 9

FET BASED BIOSENSOR: RESEARCH BACKGROUND

The immune system in our body protects us from microorganisms and other
chemical agents. This system is made up o f special cells, proteins, tissues and organs and
is continuously monitoring the body for the presence o f pathogens (foreign substance like
bacteria, virus, or other microorganisms). More specifically, the immune system looks for
the presence o f an antigen; which is a molecule (mostly protein) attached to a pathogen.
The presence of an antigen triggers the immune system to produce a specialized protein
called an antibody that locks onto the specific antigen and eventually destroys the
pathogen. The world we live in today is a complex place, where we consume more
processed foods, commonly travel across continents, produce industrial waste that
contaminates water sources, and face the possibility o f biological and/or chemical
warfare. Advancement in science and diagnosis o f diseases over the last century has
improved human health significantly, but there are a growing number o f factors,
including food and water, that could have an adverse effect on our health or could prove
to be fatal. It is a never-ending quest to develop technologies that can detect biological
and chemical pathogens, contaminants or other agents that can cause the spread o f a
disease and infection. The field o f pathogen detection is expansive, and as shown in
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Figure 9-1, research areas like water and environmental control, food industry and
clinical diagnosis account for more than two-thirds o f all the research in this field [48].

Areas of interest for pathogen detection
Defense

Other Areas

Food Industry

Water
&

Environment
Clinical

Figure 9-1: Areas o f interest for pathogen detection [48].

9.1

Diagnostic Targets

In conventional diagnosis, the sample taken from the patient travels to a
laboratory where a skilled technician runs various diagnostics tests to confirm whether
the patient tests positive or negative for a particular disease. Any clinical diagnostic test
is designed to detect a specific analytical ‘target’ in the patient’s sample. The target list
includes proteins, nucleic acids, metabolites, drugs, dissolved ions, human cells, and
microbes. The sample can be a patient’s blood, saliva, urine, or other bodily fluids or
semi-fluids. When it comes to detecting pathogens, there are two popular diagnostic
targets: nucleic acids and proteins.
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9.1.1

Nucleic Acids
The diagnosis based on nucleic acids is often referred to as “molecular

diagnostics”. There are two approaches to molecular diagnosis to measure the DNA or
various types o f RNA to assay particular genomic or genetic details o f a patient, or to
assay the nucleic acid sequence unique to the invading pathogens. The assay is based on
the isolation, amplification, and quantification o f the target nucleic acid sequence.
Techniques like Polymerase Chain Reaction (PCR) are very common in molecular
diagnostics. Kary B. Mullis developed the PCR technique in 1983 and in 1994 he and
Micheal Smith were awarded the Nobel Prize in chemistry for their work. These
techniques are highly selective and sensitive, but they are also more expensive,
cumbersome and time consuming than other assay techniques [49].
9.1.2

Proteins
Proteins, including enzymes, antibodies and some hormones, are common targets

in clinical diagnosis. The ability o f an antibody to identify and form complexes with the
corresponding antigen is highly specific and forms the basis o f immunoassay techniques.
This extremely specific affinity o f antigen-antibody lends immunoassays with a very high
level o f sensitivity. There are multiple ways to detect this specific antibody-antigen
(immunoagents) interaction (immunointeraction), and the most common approach
involves immobilizing one of the immunoagents on a substrate and then exposing the
immobilized immunoagent with its corresponding immunoagent solution. The exposure
leads to interaction and eventual formation o f an antibody-antigen complex on the
substrate. The detection process quantifies the complex formed on the substrate. To
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simplify the quantification process, one o f the immunoagents is attached with commonly
used labels like radioactive markers, enzymes or fluorescent dyes.
The use o f radioactive markers dates back to 1960 when Solomon Berson and
Rosalyn Yalow successfully measured endogenous plasma insulin using radioisotope
[50]. Even though the radioimmunoassay (RIA) technique was hugely popular, and
earned Yalow the Nobel Prize in physiology and medicine in 1977, this technique
required special facilities and there was great concern regarding the safety o f laboratory
personnel when handling radioactive waste. Alternatives were explored, and in the early
1970s, the idea o f using enzymes was put forth at ERIAC (European Radiolmmuno Assay
Club). Peter Perlmann and Eva Engvall conceptualized and later developed the enzymelinked immunosorbent assay (ELISA) technique, publishing their first paper in 1971 that
demonstrated the quantitative measurement o f IgG in rabbit serum with alkali
phosphatase [51]. Today, ELISA is the most commonly used enzyme immunoassay
technique with different schemes. The direct ELISA technique is the simplest of
schemes, whereas the ‘sandwich’ method and competitive binding method are the most
widely used.
These conventional techniques however have several limitations. To begin, they
require a laboratory setup with a highly qualified technician who can execute the
complex multistage process and analyze the results. The analysis can take several hours,
making it unsuitable for applications where quick determination o f analyte is required.
Finally, equipment miniaturizing and measurement automation is difficult or impossible.
Progress in nanotechnology has made it possible to miniaturize many of the tools
used in conventional immunoassay tools. There is immense interest and progress in
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point-of-care diagnosis (POC). POC diagnostic tools employ in vitro diagnostic tests,
which are tests that do not require any sample pre-preparation, a well-equipped
laboratory setup or a skilled technician. At the heart o f any POC system is a biosensor.
The term ‘biosensor’ or ‘immunosensor’ is used for alternative immunoassay systems
that overcome the limitations o f conventional immunoassay techniques. These
alternative systems are still based on the same basic principles o f antigen-antibody
interaction used in conventional assays, but as they are automated, they are more
efficient, sensitive, and also faster than their conventional counterparts and have the
ability to acquire data directly [52]. The biggest advantage o f POC diagnosis is the short
amount o f time required to get an “answer”, as the result is available in seconds
compared to hours [53],

9.2

Biosensors

Leland Clark was a pioneer in the development o f the heart-lung machine. Clark
was an experienced physiologist who, during a surgery, could correctly adjust the oxygen
levels by visually judging the redness o f the blood. In his attempt to automate the process
o f oxygenating blood circulation, he developed the oxygen sensor, or more commonly
known as the Clark electrode. Later, while he was trying to calibrate the electrode
(deoxygenating it) by adding small amounts o f enzyme glucose oxidase, he realized he
could use his device as a glucose sensor. In doing so, Clark had built the first ever
biosensor. In 1992, at the World Congress on Biosensors in Geneva, Switzerland, he was
honored with a special recognition o f “Father o f Biosensors” [54].
Lazcka et al. have managed to quote a source that defines a biosensor [48].
According to their source, “Biosensors are analytical devices incorporating a biological
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material (e.g., tissue, microorganisms, organelles, cell receptors, enzymes, antibodies,
nucleic acids, natural products, etc.), a biologically derived material (e.g., recombinant
antibodies, engineered proteins, aptamers, etc.) or biomimic (e.g., synthetic catalysts,
combinatorial ligands and imprinted polymers) intimately associated with or integrated
within a physicochemical transducer or transducing microsystem, which may be optical,
electrochemical, thermometric, piezoelectric, magnetic or micromechanical.'” The basic
block diagram o f a biosensor is shown in Figure 9-2. In general, a biosensor is composed
o f two parts: a) a sensor system that allows interaction between biological elements, and
b) a transducer that generates a signal employing principles o f biological molecular
recognition.. Most of the biosensors use three main biological elements for recognition,
namely enzymes, antibodies and nucleic acids.

SAMPLE

I

biologically

sensitive
coating

SENSOR

TRANSDUCER

OUTPUT

Figure 9-2: Basic block diagram o f a biosensor [55].

Based on the transducing mechanism, biosensors can be classified as optical
biosensors, gravimetric biosensors and electrochemical biosensors.
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9.2.1

Optical Biosensors
The good selectivity and sensitivity o f optical biosensors make them the most

popular types o f biosensors. While fluorescence detection is the most commonly used
technique in optical biosensors, there are increasing numbers o f optical biosensors based
on other smart techniques such as surface plasmon resonance (SPR), and photonic crystal
nanostructures.
Fluorescence detection has been used in conventional techniques like ELISA and
PCR in which immunoagents are conjugated with fluorescent compounds. In fluorescent
compounds, a valence electron can absorb light from an external excitation source and
make a transition to an excited singlet state. When this electron returns to its ground state,
it emits a photon (light) with lower energy (longer wavelength). There are many types o f
fluorescent markers, but the most commonly used is fluorescein isothiocyanate (FITC)
and quantum dots that are increasing in popularity due to the fact that they produce
stronger fluorescent signals and increased sensitivity. A technique based on the transfer
o f energy from donor fluorophore to an acceptor fluorophore, also called fluorescence
resonance energy transfer (FRET), has been used to detect listeria and salmonella
contamination in food [56]. Quantum dots are now being used in FRET since they make
excellent donors [57].
When light (photon) is incident upon a solid or liquid, the electrons at the surface
are set into oscillations, and Surface Plasmon occurs when the frequency o f electron
oscillation is equal to the frequency o f incident photon. Under specific conditions, the
incident photon couples with the surface plasmon to generate electromagnetic waves
called Surface Plasmon Polaritons (SPP). The boundary o f a metal-dielectric interface
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can guide these electromagnetic waves over a very short distance (< 100-200 nm) before
they lose their energy due to absorption in the metal or radiation into free space. These
SPP are very sensitive to changes in thickness or refractive index along the path they
travel near the boundary o f the metal-dielectric interface. An SPR based biosensor
measures this change in refractive index due to the adsorption o f antigen-antibody [58].
It was Lord Rayleigh who first studied the propagation o f electromagnetic waves
in periodic media. In early 1887, he studied crystal structures that could prohibit light
propagation through their planes. In 1987, researcher Eli Yablonovitch published a paper
on his attempts to achieve threshold-less LASER by increasing reflective feedback levels
into the light-emitting medium [59], In the same year, researcher Sanjeev John published
a paper where he was trying to localize light by using a periodically varying refractive
index [60]. Later, they both realized that they were investigating the same type of
structure, and Eli Yablonovitch coined the term Photonic Crystals. According to Eli
Yablonovitch, to be called a photonic crystal, the crystal must satisfy two important
criteria: the structure has to have 2D or 3D periodic structure and the photonic band
structures should have a high index o f contrast (> 2) [61]. Photons behave similarly to
electrons in photonic crystals due to the presence o f photonic band gap (PBG). Photonic
crystals can block a range o f photons; photonic band gap is the range o f photon energy or
frequency that cannot propagate through the photonic crystal. The fabrication o f photonic
crystals is complicated, but simpler techniques like using nano porous hydrogel to
fabricate photonic crystal have been used to detect immunoglobulin G (IgG) antibody
[62].
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9.2.2

Gravimetric Biosensors
Gravimetric biosensors detect the change in mass following the antigen-antibody

complex formation, and the most common approach to detect the change in mass is to use
piezoelectric detectors. For a piezoelectric material, the resonance frequency changes
when mass is added to the material. The relationship between resonance frequency
change and the mass is given by Sauerbrey equation:
-2 .3

x

AF = -----------

1 0 6 Fo2Ara

5------ .
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Eq. 9-1

Where AF is the change in resonant frequency in Hertz, F0 is the resonant
frequency o f the crystal in MHz, Am is the mass deposited in grams and A is the area over
which the mass is deposited [63].
These types o f biosensors have been used to detect bacteria using probes modified
with immobilized antibodies [64], [65]. The resonant frequency o f the probe is then
measured using a quartz crystal microbalance (QCM).
9.2.3

Electrochemical Biosensors
As mentioned earlier, optical biosensors are the most commonly used biosensors

due to the fact that they have good sensitivity and selectivity; even conventional
techniques like ELISA are based on optical detection and still remain very popular.
Optical biosensors do suffer from several drawbacks, however, including bulky
monochromators, light sources and detectors. The most important limiting factors are the
minimum sample volume and the path length requirements that are set by the LambertBeer law to achieve certain performances [66],
Electrochemical biosensors come across as the most promising alternatives to
these optical biosensors and are more common in monitoring and the diagnostic test in
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clinical analysis. Advancements in micro and nano scale fabrication make it possible to
miniaturize the electronics involved in electrochemical biosensors, leading to lower-cost,
better multiplexing, and to the possibility o f high-throughput analysis while using very
small volumes o f samples. The biggest advantage that electrochemical sensors have over
optical counterparts is the fact that the volume o f the sample does not affect the
sensitivity o f the electrochemical sensors.
Any electrochemical biosensor is designed to detect the changes in electron
(charge) transfer (either voltage or current changes) when immunoagents interact.
Depending on the parameter detected, these sensors are classified as: amperometric
(current), potentiometric (constant voltage), or impedimetric (alternating
voltage/impedance).
9.2.3.1

Amperometric Electrochemical Biosensors
Detecting the current is the most commonly used technique in electrochemical

sensors. The sensors are biased such that the immunointeraction produces a current
directly or indirectly, and usually the linear relationship between the current and the
analyte concentration is known. Based on the known linear relationship, the
concentration can be directly evaluated from the measured current. There are certain
situations where the immunointeraction will not produce any charge transfer. In such
cases, redox mediators are introduced that are able to reversibly exchange charge
between the sensor and immunoagents [67], [68].
9.2.3.2

Potentiometric Electrochemical Biosensors
These sensors monitor the change in potential at the working electrode with

respect to a reference electrode. The field-effect is the dominant technique used in these
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sensors. Traditionally, an ion-sensitive field effect transistor (ISFET) involved using a
reference electrode to detect biological elements, but there is a very useful variation o f
ISFET utilizing the semiconductor field-effect for detection [69]. The application o f these
types o f electrochemical biosensors was not very common in the past and there are
certain problems associated with these devices that limit the growth. The biggest
challenges involved in using these sensors are a) fabrication and packaging, b) poor
reproducibility, c) poor detection limits, and d) poor device stability.
9.2.3.3

Impedimetric Electrochemical Biosensors
Impedimetric technique is more commonly known as electrochemical impedance

spectroscopy (EIS). The commonly used structure makes use o f interdigitated electrode
array structure as shown in Figure 9-3. The detection technique involves applying a small
voltage across two electrodes and sweeping the frequency while simultaneously
recording the impedance (conductance). Since the impedance is a complex function o f
frequency, it is easier to detect any change in dielectric constant due to the formation of
complexes after the immunointeraction. The main advantage o f these sensors is they do
not need any kind o f labels as compared to other electrochemical sensors that need labels.
The label free approach makes these sensors suitable for rapid detection o f foodbome
pathogenic bacteria [70], [71]. However, the detection limits for these sensors are poor
when compared to other traditional techniques [48].
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Figure 9-3: An interdigitated electrode (IDE) array.

9.3

Nanotechnology and Biosensors

Nanotechnology is a multidisciplinary field that involves studying, creating and
manipulating materials to develop devices and systems. Typically, at least one dimension
o f the nanomaterial and nanostructure is in the range o f 1-100 nm. These novel
nanomaterials and nanostructures display unique physical and chemical properties due to
quantum size effect, surface effect, and quantum-tunnel effect. Fundamental concepts in
condensed matter physics drive the developments in artificial inorganic nanostructures. It
was Leo Esaki who first introduced the concept o f ‘artificial solid’ when he developed
novel semiconductor quantum devices, in which the tunneling o f electrons could be
systematically controlled [72]. In 1973, Esaki was awarded the Nobel Prize in Physics.
The quantum mechanical scattering o f the valence electrons by the atoms is responsible
for the electronic and optical properties o f a semiconductor. In the first artificial solids,
the semiconductor atoms were arranged in a specific way to create artificial ‘quantum
wells’; electrons passing through this potential were then scattered along the designed
path. The quantum wells make it possible to control the spacing between the electronic
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energy levels systematically by adjusting the length scale over which the potential varies,
compared to the electron wavelength [73].
The use o f nanomaterials and/or nanostructures in biosensors is opening up new
ways for signal transduction, and allowing for rapid analysis o f multiple substances. In
one-dimensional nanostructures, every atom in the structure is a surface atom, which
offers maximum surface-to-volume ratio. This is a major advantage, and when these ID
nanostructures are used in the biosensors, the high surface-to-volume ratio contributes to
an increase in sensitivity [74]. Another key advantage o f using nanostructures is the
possibility to integrate a large number o f devices on a single small chip [75]. Here is a
brief review o f the different kinds o f nanostructures used in the biosensors.
9.3.1

Nanoparticles
As discussed in Section 9.2.1, quantum dots have been used as replacements for

conventional fluorophores in optical biosensors because they can produce stronger
fluorescent signal and increase the sensitivity. Quantum dots are also a good choice for
newer optical techniques like FRET. A thin layer o f gold nanoparticles coated on the
nano pore structure o f a Fabry-Perot interferometer significantly enhances the optical
signal due to the localized surface plasmon resonance effect [58]. Gold nanoparticles can
also be used as fluorescence quenchers (energy acceptor) in an optical biosensor to detect
specific DNA sequences [76]. Colloidal gold has more surface area, and when used in an
electrochemical DNA biosensor, it enhances the amount o f immobilized DNA, which in
turn lowers the detection limit o f the biosensor [77]. Cell separation techniques use
magnetic nanoparticles to label the cells, and then by applying magnetic field gradients,
cells can be isolated and manipulated [78]. Paramagnetic particles make an interesting
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choice in immunoassay techniques. These particles do not require chemical or
electromagnetic stimulations, and they can cause perturbation in the applied magnetic
field that can be easily detected with suitable electronics [79].
9.3.2

Nanowires
Nanowires can be classified as metallic or semiconducting. Nanowires exhibit

highly reproducible electrical [80], [81] and optical properties [73], and hence, provide
unique opportunities to develop novel biosensors. Metallic nanowires can be grown in
porous alumina templates [82], [83]. Semiconducting nanowires can be grown either
using the top-down approach or the bottom-up approach [84]—[86]. Among
semiconducting nanowires, silicon nanowires are more commonly used since they are
easier to fabricate. Existing technologies used to fabricate microelectronics are all based
on silicon and can be easily applied in the fabrication o f silicon nanowires. Other
semiconducting nanowires made out o f ZnO also show the ability to detect bio molecular
interactions [87]. The high surface-to-volume ratio o f silicon nano wires has helped to
achieve very low detection limits [88], [89]. Another advantage o f using nanowire is the
label-free nature o f the electrical detection. In most cases, the analyte molecule is directly
detected on the surface o f the nanowire through sensitive molecular interaction and no
label is required [90], [91].
9.3.3

Carbon Derived Nanostructures
Carbon nanotube (CNT) and diamond are two widely employed carbon

polymorphs in fabricating electrodes for electrochemical sensors [92]. Depending on the
structure, CNTs can be classified as single-wall carbon-nanotubes (SWNTs) and multi
wall carbon-nanotubes (MWNTs). Since every atom in a CNT is a surface atom, they
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form an ideal class o f ID nanostructures that could exhibit ideal sensitivity at the single
molecule level [46]. Transfer o f charge from one electrode to another is a very important
aspect in any electrochemical reaction, and it has been shown that CNTs promote
electron-transfer reactions o f proteins [47].
The biggest hurdle in using CNT for biosensors is the process involved in
assembling the nanostructure into the sensor. The commonly used technique involves
dispersing nanotubes in an aqueous or organic solution and then depositing them on a
substrate. The contact electrodes are then created using electron-beam lithography. Even
though this assembly technique is simple, the process o f creating contacts is very random
and yields a very low throughput. One o f the strategies used to tackle this problem is
based on AC dielectrophoresis. Single CNT or a bundle o f CNTs can be aligned between
a pair o f contact electrodes by controlling the time, voltage, and frequency o f the applied
AC voltage [93]. Another alternative is to use catalyst seeds at predefined locations [94].
However, there is still no established standard process to the assembly o f single CNT.
Instead, it is easier to produce a network o f carbon nanotubes (thin film) that involves the
use of chemical vapor deposition (CVD) and does not require any catalyst seed. A
network o f CNT has been used in label-free detection o f DNA hybridization [95]. The
sensitivity o f these devices is lower due to an increased number o f CNTs, but it is
possible to produce devices on a large scale [46].
The excellent biocompatibility, low background current, wide potential window,
and good chemical stability make the diamond the best known electrochemical transducer
[96]—[98], A diamond is chemically inert and shows the strongest bonding stability to
DNA [99]. Even though a diamond possesses all these excellent properties, it has
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struggled to expand its applications in life sciences, the primary reason being the high
costs of production and refinement [92].

9.4

Carbon Nanotube

Polymorphism, or allotropy, is a characteristic o f a material that can have more
than one crystal structure. Carbon has three important crystalline allotropes: diamond,
graphite and buckminsterfullerene. Diamond and graphite were the best-known allotropes
o f carbon until 1985 when buckminsterfullerene (called the ‘buckyball’) was discovered
by Robert F. Curl, Harold W. Kroto and Richard E. Smalley [100]. They were awarded
The Nobel Prize in Chemistry in 1996. The buckminsterfullerene molecule has a total o f
60 carbon atoms (also known as C6o) and can be imagined as a soccer ball, with each
vertex on the seam replaced by a carbon atom as shown in Figure 9-4.
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Figure 9-4: A buckyball structure with carbon atoms at every vertex o f an imagined
soccer ball. The red lines indicate single bond and yellow lines indicate
double bond [102].

The buckminsterfullerene crystal is a semiconductor and it exhibits
superconductivity when it forms a compound with alkali metals at low temperatures.
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Along with diamond, graphite and fullerene crystals, carbon also exists in other
crystalline forms and structure. Amorphous carbon has no crystal structure, but it is
defined as a structural allotrope. Carbon nanotube is another such structural allotrope o f
carbon that was discovered in 1991 by Iijima [101]. The structural allotropy in carbon is
related directly to the different hybridization that carbon atoms can assume. A diamond is
formed when the four valence electrons are shared equally (sp3 hybridization).
In graphite, three electrons are equally shared (sp2 hybridization) and the fourth
electron is allowed to remain delocalized among all atoms. The sp2 hybridization results
in a structure that has strong in-plane bonds and weak out-of-plane bonds; this is the
reason why graphite can slide along the planes and is considered a soft material.
Fullerenes and nanotube structures o f carbon are also formed due to sp2 hybridization.
Under normal ranges o f pressure, bulk graphite is thermodynamically stable even at high
temperatures, but its behavior changes when the size o f the crystal is very small. For a
very small size, the number of carbon atoms is finite and the density o f dangling bond
atoms is high. To become energetically stable, these atoms close onto each other to
remove the dangling bonds. When the number o f carbon atoms is less than a few
hundred, the structures formed correspond to linear chain, rings and closed shells
(fullerenes) [100].
9.4.1

Structure o f Carbon Nanotube
According to Euler’s principle, one needs exactly 12 pentagons to close a

hexagonal lattice completely with a topological curvature; hence, for a
buckminsterfullerene (C6o) molecule, there are always 12 pentagons and many hexagons
(C 2n has n-10 hexagons). Carbon nanotubes are greatly elongated fullerenes and can be
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produced with 12 pentagons and millions o f hexagons. As shown in Figure 9-5, a carbon
nanotube (CNT) is a long cylinder made o f the hexagonal lattice o f carbon bound by two
half-hemispherical fullerenes at the ends. The diameter o f the tube will depend on the
size o f the half-hemispherical fullerene. The cylindrical open-ended structure o f the tube
can be conceptualized as rolling a sheet o f graphene (single layer o f graphite) to form a
seamless match between the open edges. On the curved surface o f the tube, the hexagonal
arrays o f carbon atoms wind around in a helical fashion introducing helicity to the
structure. To close the ends o f the tube, pentagons are nucleated at some stage in the
growth process.

Figure 9-5: The basic cylindrical structure o f a carbon nanotube with both ends
closed by semi-hemispherical buckyball [103].

There are two structural variations found in nanotubes. The first, called the multi
walled carbon nanotube (MWNT) were discovered first and are made o f concentric
cylinders placed around a common central hollow. The diameters o f these tubes vary
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from 2 to 25 nm, and the distance between each cylinder is 0.34 nm. The second, called
the single-walled carbon nanotube (SWNT), are single-layer cylinders extending from
end to end with diameters from 1-2 nm [92]. Rolling a graphene sheet into a carbon
nanotube can be done in several ways as long as the dangling bonds on both edges are
matched. This process introduces chirality in carbon nanotubes, and a lattice vector Ch
uniquely specifies the fiber diameter and chirality
Ch =

4- n 2a 2 = (n x, n 2).

Eq. 9-2

Where m , ri2 are integers and aj, a2 are the unit vectors. To understand chirality,
let us consider the scenario depicted in Figure 9-6.

Figure 9-6: A carbon nanotube formed by rolling a sheet o f graphene. The chiral
angle is denoted by 6, ai and ci2 are the graphene unit vectors [103].

The chiral vector Ch connects two sites A and A/ on the one-dimensional graphene
crystal. Connecting together points A and A/ form the nanotube and the lightly dotted
lines that are perpendicular to Ch show the cylinder joint. If a — 1.42 x V3 A0 is the
lattice constant, the fiber diameter d is then defined by
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d=

|Ch |

a y jn \ + n xn 2 + n |
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Eq. 9-3

therefore the chiral angle that defines the direction o f the lattice vector is given
by

0 =

arctan

Eq. 9-4

(2% + n 2)

The lattice vector Ch offers a range o f orientation for carbon nanotubes ranging
from zigzag direction [0 = 0° or (n, 0)] to armchair direction [0 = ± 30° or (n, n)] and
hence these nanotubes are called zigzag nanotubes and armchair nanotubes, respectively,
in Figure 9-7. All the other types o f nanotubes are simply referred to as chiral nanotubes.

(a) Armchair fiber

(b) Zigzag fiber

Figure 9-7: Arrangement of carbon atoms in armchair carbon nanotube (left) and zigzag
carbon nanotube (right) [104].

9.4.2

Electronic Structure o f Carbon Nanotube
CNTs have unique electrical properties due to their chirality. Armchair nanotubes

are metallic, whereas the zigzag and chiral nanotubes are either metallic or
semiconducting [103]—[105]. Figure 9-8 shows how the unit vectors can be configured to
create a metallic or semiconducting nanotube.
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Figure 9-8: Possible vectors for chiral nanotubes. Circled dots and dots represent
metallic and semiconducting nanotube respectively [103].

The interesting properties o f CNTs are associated to their ID shape along with sp2
and n bonding between the carbon atoms. In graphite, the electronic bands are formed
because the it electrons between two adjacent layers are free to move between the bonds.
The finite tube circumference o f carbon nanotubes restricts the number o f possible
electron states and a band gap opens up at the Fermi energy. The density o f states
represented as unit o f states per unit cell o f 2D graphite for two different zigzag
nanotubes (m, m) = (10, 0) and (9, 0) is shown in Figure 9-9.
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Figure 9-9: Density o f states for a) zigzag nanotube (10, 0) and b) zigzag nanotube
(9, 0). The dotted line shows density o f states o f 2D graphite [103].

The singularity arising due to ID structure is apparent at the edge o f every energy
level. For the nanotube with m= 10, there is an energy gap at the Fermi Level (E=0), but
for the nanotube with ni= 9 there are finite density o f states. This shows that metallic and
semiconducting nanotubes can be fabricated by just changing the diameter o f the tube.
The condition for the nanotube to be metallic is
2 n x + n 2 = 3q ,
where q is an integer.

Eq. 9-5
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The relationship between the band gap (Eg) and the diameter o f a semiconducting
CNT is given by

Es = f

Eq.9-6

For metallic CNTs ( m / m ) there exists a second band gap. This band gap is related to the
diameter o f the tube as follows [106]:
£a = T

E q.9-7

The resistivity o f a material depends on the number o f charge carriers and the
scattering these charge carriers experience inside the crystal. In well-fabricated carbon
nanotubes, the electrons can travel over distances o f up to several micrometers without
getting scattered (ballistic transport) [107], [108]. When carbon nanotubes are integrated
into the devices, the contact resistance between the tube and the metal electrode becomes
very important. The work function variation from one metal to another is very large;
depending on the type of metal used, the contact resistance shows different behavior.
Metals like Ti and Pd lead to p-type conducting behavior, while Mg contact electrodes
show ambipolar characteristics. Contacts made out o f Ca mostly show n-type conduction
behavior. The values o f contact resistance can be calculated theoretically using the first
principle; these calculations show that contacts made out o f Ti have the lowest resistance
with CNTs followed by Pd, Pt, Cu, and Au.

9.5

Carbon Nanotube Based Immunosensor

An immunosensor is a special type o f biosensor that exclusively monitors the
antibody-antigen interaction [109]. An immunosensor can be a direct or an indirect type
o f sensor. In a direct immunosensor, there is a direct detection o f the antibody-antigen
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reaction with or without the use o f labels. For an indirect immunosensor, the biological
reaction takes place in a reaction tube and a sensor measures the product o f that reaction.
Carbon based biosensors are commonly used because o f their low cost, good electron
transfer kinetics and biocompatibility. Carbon nanotubes display high mechanical
strength, chemical stability and electrical conductivity, which make them ideal for use in
the sensors.
The electrochemical signal generated from an antigen-antibody interaction in a
CNT based immunosensor can be detected in two ways [110]. The first strategy is based
on building a CNT based field-effect transistor (FET). The typical procedure involves
binding the antibody to the CNT and then allowing the antigen to interact with the
antibody. The electrochemical signal generated due to the antigen-antibody interaction
changes the electric field, which in turn modulates the drain current o f the transistor. The
second approach is an indirect detection method where, just like the first strategy, an
antibody is attached to the CNT and the antigen, then binds to the antibody. The CNT is
then exposed to a second antibody that has a tag that is either redox active or can
facilitate electrochemiluminescence. The label-free approach o f the first strategy is more
appealing and extensively utilized in modem biosensors.
9.5.1

Field-Effect Transistor (FET) Based Immunosensor
The use o f silicon as a substrate in electrophysiological measurements was started

in the late sixties at Stanford University [111]. In 1970, Bergveld introduced the idea o f a
solid-state device that could measure ion-concentrations in electrochemical and
biological environments [112]. Besides measuring the electrical potential, this device
could measure the ion concentrations, and it was called an ion sensitive field effect
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transistor (ISFET). The ISFET is a special type o f MOSFET. As shown in Figure 9-10
instead o f a conventional gate found in a MOSFET, the gate in an ISFET is a reference
electrode that is inserted in an aqueous solution that is in contact with the gate oxide.

o
R eference
electrode

S o u rce

S ource

(a)

Drain
ISFET

M OSFET
(b)

Figure 9-10: Construction o f a) conventional MOSFET and b) ISFET proposed by
Bergveld [113],

The ISFET became popular after its invention in 1970, so much so that in the next
thirty years it accounted for more than 600 papers on the subject and inspired the
development o f many other devices, such as EnzymeFET (ENFETs), ImmunoFETs
(IMFETs), etc. [113].
After the discovery o f CNT in 1991, the semiconducting and metallic nature of
CNT was extensively studied in the early 90s. The field-effect behavior in CNT was first
reported from a metallic CNT operated at very low temperatures [114], whereas the first
transistor fabricated with a single semiconducting CNT operating at room temperature
was reported later in 1998 [115]. The ability o f this transistor to operate at room
temperature opened the door for various applications in the following years. The first
CNT based transistor reported by Tans et al. is shown in Figure 9-11. The gate is a
silicon wafer with a 300 nm thick layer o f silicon oxide. The single semiconducting CNT
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between the two Pt electrodes was produced by condensation o f laser-vaporized carbonnickel-cobalt mixture at 1200° C [116].

Pt

Si02

Pt

Si02

Figure 9-11: a) AFM image o f single CNT on top o f three Pt electrodes b) schematic
side view of the transistor [115].

A detailed study o f CNT based FET revealed the transport in CNTs is dominated
by holes at room temperature and the transistor exhibits p-type behavior [117]. To get the
output characteristic, the source-drain voltage was swept from -200 mV to +200 mV with
gate voltages o f Vg = -6, 0, 1,2, 3 ,4 , 5, and 6 V. The output characteristic is shown in
Figure 9-12a. The transfer characteristic was obtained by sweeping the gate voltage and
incrementing the drain-source voltage from 10-100 mV in the steps o f 10 mV. As shown
in Figure 9 -12b, the conductance o f the transistor can be modulated with the gate
electrode. This study suggested that the SWNCT-FET behaved liked an ordinary FET,
but it was later proven that it is the Schottky barriers at the CNT-metal contacts that play
a central role in modulating the conductance o f the transistor [118]—[120].
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Figure 9-12: a) Output characteristic and b) transfer characteristic o f SWCNT-FET
[117].

A Schottky barrier, as shown in Figure 9-13, is a potential energy barrier created
when a metal and semiconductor are brought in contact. The Schottky barrier height, O b ,
is the difference between the interfacial conduction band edge Ec and Fermi level £>-. The
metal-semiconductor contact can behave as a rectifier (electrons flow only in one
direction) or as a resistor (electrons can flow in both directions) depending on the
barrier’s height. If the barrier is high enough, a depletion region is formed and the contact
is a rectifying type, whereas if the barrier is low, the contact is ohmic (acts as a resistor).
At the start o f the century, it was demonstrated that the surface adsorption o f various
molecules and the change in their electrostatic charges vary the conductance o f a
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nanotube significantly [121]—[123], This opened up the avenue for using SWCNT-FET
for biomolecule detection.

Semicon.

E-p —

Figure 9-13: Formation o f Schottky barrier at metal-semiconductor junction for zero
bias [124],

9.5.2

Sensing Mechanism in SWCNT-FET Based Immunosensor
The exact sensing mechanism in SWCNT-FET based immunosensor was a topic

o f debate [125]. The initial work on SWCNT-FET as an immunosensor included
detection o f protein A and biotin-streptavidin [126], [127], and it suggested the
conductance o f the CNT transistor changed due to the electrostatic gating. The various
functional groups present in proteins lend them surface charges, and these charges exert
electrostatic gating to alter the carrier density in the nanotubes [126]. A more detailed
study later suggested that the region near the edge o f the nanotube-metal contact
(Schottky Barrier effect) was the dominant sensing region and was more sensitive to
charge on the absorbed protein [128]. An ultrasensitive immunosensor fabricated by
modifying the geometry o f CNT-metal contact is capable o f detecting proteins as low as
1 pM [129],
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Work done on DNA sensors also suggests that the modulation o f the Schottky
barrier at the metal-CNT contact by efficient hybridization is the dominant sensing
mechanism [130], [131]. However, Dekker et al. has concluded that the sensing in an
SWNT-FET based immunosensor is dominated by a combination o f electrostatic gating
effect and Schottky barrier effect, where the electrostatic gating is more reliable along the
bulk o f the SWCNT [132]. To prove the electrostatic gating was more reproducible, they
carried out experiments with two types o f devices: one with the passivized CNT-metal
contacts to eliminate the chance o f Schottky barrier effect, and the other with non
passivized CNT-metal contacts, which allowed the Schottky barrier effect. The behavior
o f the device with non-passivized metal-SWCNT contact before and after the protein
adsorption is shown in Figure 9-14. The electrostatic gating shifts the semiconducting
bands downwards after protein adsorption (indicated by the red curve). The Schottky
barrier effect alters the difference between the metal and SWCNT workfunctions.

a. Gating

b. Schottky

Figure 9-14: The black curve corresponds to device characteristic before protein
adsorption and the red curve corresponds to the device characteristic
after protein adsorption a) electrostatic gating effect b) Schottky barrier
effect [132],

Since most o f the biomolecules, including proteins, are suspended in
physiological buffer solutions, the interface between the solution and the charged surface
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o f a sensor plays a vital role in detection [133], [134]. When a charged surface comes in
contact with an ionic solution (electrolyte), the oppositely charged ions in the solution are
attracted towards the surface-electrolyte interface and form an electrical double layer
(EDL) as shown in Figure 9-15. The distance from the interface where the electrostatic
field strength has dropped to 1/e o f its initial value defines the thickness o f this electrical
double layer. This distance is also called the Debye screening length, k ', and its value is

■

- - p

.

where q is the elementary charge, k is the Boltzmann’s constant, T is absolute
temperature, eO is the permittivity o f vacuum, e is the dielectric constant, and / represents
the ionic strength. For 1-1 salt I can be replaced with the concentration o f ion (c). For
most o f the physiologically relevant buffer solutions with ionic strength o f ~ 100 mM, the
Debye length k 1 is around 1 nm and the surface potential is completely screened at a
distance o f a few nanometers away from the interface. So to successfully detect a protein
adsorbed on the SWCNT surface, the dimensions o f the protein have to be less than lnm.
Normally, the dimensions of the proteins are much larger (around 10 nm), so to tackle
this problem, most o f the sensors based on SWCNT or nanowires are operated in buffers
with low ionic strength (~1 nM to 10 mM) [80], [132], [135], [136].
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Antibody
Antigen

Figure 9-15: Schematic representation o f electrical double-layer and the antibody
adsorbed on the interface [137].

9.6

Protein Immobilization

Immobilization can be defined as the attachment o f bio molecules to a surface,
which results in the reduction or complete loss o f mobility. To achieve good reproducible
selectivity and sensitivity in an immunosensor, it is crucial that the antibody molecule is
bound to the transducer surface in a highly controllable way and is oriented in a way that
is optimal for the specific antigen binding without affecting its activity [138]. The
orientation o f the antibody should be such that the binding site o f the protein is optimally
accessible for the target antigen. The immobilization techniques are mainly based on the
following three mechanisms: physical, covalent, and bio-affinity immobilization [139].
9.6.1

Physical Immobilization
Physical adsorption is the simplest and most inexpensive method to immobilize

proteins. The adsorption occurs due to the weak interactions between a protein and the
surface; factors like hydrogen bonds, electrostatic interactions, hydrophobic interactions,
and Van der Waals interactions are responsible for adsorption. This technique is simple
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and involves incubating the substrate in a protein solution followed by the rinsing off o f
the non-adsorbed protein. The drawbacks o f this technique include random orientation
and weak attachment as some buffers or detergents may wash off the protein during the
assay.
9.6.2

Covalent Immobilization
A more robust way to immobilize proteins on the surface is by means o f covalent

bonds. This technique requires the presence o f two mutually reactive chemical groups on
the surface o f the substrate and the protein. The functional group on the surface o f the
substrate is generated by chemical treatment and the covalent bonds are formed between
the exposed side-chain functional groups o f the protein and the modified surface
substrate. Table 9-1 shows the required functional groups on the surface o f the substrate
corresponding to the available groups on the protein [139].

Table 9-1: Commonly available functional groups in proteins and functional groups
required on the substrate surface.

Side groups

Amino acids

-nh2

Lys, hydroxyl-Lys

-SH

Cys

Functional groups required on the
substrate surface
Carboxylic acid
Active Ester (NHS)
Epoxy
Aldehyde
Maleimide
Pyridyil disulfide
Vinyl sulfone

-COOH

Asp, Glu

Amine

-OH

Ser, Thr

Epoxy
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9.6.3

Bio-affinitv Immobilization
This technique is based on complementary affinity interactions between

biomolecules and generates a well-oriented and homogenous attachment o f the antibody.
It is also possible to detach proteins and make repeated use o f the same surface. The
commonly used techniques include Avidin-Biotin system, His-Tag system, DNA-directed
immobilization, and Protein A/Protein G-mediated immobilization. The Protein A/Protein
G-mediated immobilization relies on the specific interaction o f the Protein A/Protein G
with the Fc constant region o f the Immunoglubolin G (IgG) molecule. The basic structure
o f IgG is shown in Figure 9-16. The first step in this technique is to immobilize the
Protein A/Protein G covalently on the surface o f the substrate. Next, the antibody (IgG) is
introduced; the specific bio-affinity o f Protein A/Protein G to the Fc region orients the
IgG such that the binding sites o f the IgG remain easily accessible for binding with the
antigen.

HOOC

COOH

Figure 9-16: Structure o f IgG where 1) Fab region, 2) Fc region, 3) heavy chain, 4)
light chain, 5) antigen binding sites, 6) hinge regions [140].
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9.7

Carbon Nanotube Thin Film

As discussed in Section 9.3.3, individual carbon nanotubes have a very large
surface-to-volume ratio and can act as an ideal sensor. Every atom in the nanotube is on
the surface acting as an individual sensing site; hence, it is possible to achieve single
molecule detection. However, there are many challenges that prevent a carbon nanotube
based sensor from operating at ideal levels [46]. One major challenge is to passivize the
contacts o f a sensor based on a single carbon nanotube. Contact passivation is critical for
sensors to detect an analyte directly in a liquid. Sensing can be achieved without contact
passivation, but then the response will be dominated by the receptors immobilized on the
contacts [130], [131].
In most o f the CNT based sensor prototypes, the contacts are passivized using Ebeam lithography, but alternate techniques must be used to be competitive with
conventional sensors. The length o f a carbon nanotube becomes a limiting factor when
techniques like photolithography or nano imprint are used. The high sensitivity o f CNT
based sensors is established on the fact that every atom o f the single CNT acts as an
individual sensing site. Normally, CNTs tend to form bundles, or networks, and the
sensitivity can drop drastically if the sensor cannot be built out o f a single CNT. Sensors
based on a single CNT should be reusable to remain competitive.
Repeated use leads to accumulation o f analyte species on the surface and
produces drifts that affect the reproducibility o f the sensor. One way to tackle this
problem is to have some kind o f on-site cleaning mechanism on the chip; the other easier
approach is to use disposable chips. For sensors based on ID structure like CNT, there
are notable variations in device characteristics. Due to these variations, it is very
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important to calibrate each sensor before use. It is thus a major challenge to develop a
reusable CNT based sensor that can be calibrated easily before deployment in a real-life
scenario. A thin film made out o f carbon nanotubes can be a good alternative to
overcoming most o f these challenges while sacrificing only some o f the sensitivity.
A carbon nanotube thin film (CNTF) can be regarded as a novel material that has
a 2D network o f randomly distributed CNTs [141]. This thin film can either be a 2D
network o f vertically oriented carbon nanotubes [142] or o f a horizontally laid network o f
nanotubes. A CNTF is usually a mixture o f metallic and semiconducting CNTs, which
makes CNTFs exhibit semiconductor-metal transition with increasing film thickness
[143], [144]. The semiconducting behavior o f CNTF in thin film transistor and sensor
applications is observed when the density o f CNTs is closer to the percolation threshold
[145], [146], [147]. Porosity in thicker CNTF (usually micrometer thick) is an advantage
in fuel cells and battery applications [148], [149], CNTF with intermediate thickness,
ranging from 10-100 nm, shows high optical transparency and electrical conductivity
[150],
9.7.1

Fabrication o f CNTF
There are two broad categories o f CNTF fabrication: Direct growth methods and

solution-based coating methods.
9.7.1.1

Direct Growth
The three major methods to fabricate CNTs are: arc-discharge, laser ablation, and

chemical vapor deposition (CVD). CVD is the most widely used method to grow CNTF
with randomly distributed or aligned nanotubes. Aligned nanotubes are central in devices
exhibiting high mobility, and they also make it possible to realize molecular electronics,
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but these devices suffer from poor statistical reproducibility [141]. As compared to films
made out o f aligned nanotubes, CNTF made out o f randomly distributed CNTs are more
reproducible and hence can be used in more practical applications [151]. The high
vacuum and high temperature involved in direct methods like CVD may not be
compatible with many substrates that are being used in the emerging plastic electronics
field. Direct methods like CVD are, however, able to produce tubes with fewer detects
and better CNT-CNT contacts that can lead to highly conductive films.
Solution-based Deposition

9.7.1.2

Solution-based deposition methods offer several advantages over direct growth
methods. These methods are carried out at low temperatures, do not require a high
vacuum, and are compatible with a wide range o f substrates. The quality o f the thin film
depends on several factors including CNT material quality, stability o f CNT dispersion,
adhesion quality, and stability on the substrate. Solution-based deposition is a two-step
process: a) preparing a stable CNT dispersion and b) coating the dispersion on the
substrate.
9.7.1.2.1

Stable CNT Dispersion

The biggest challenge in fabricating CNTF is to prepare a stable dispersion o f
CNTs. The large aspect ratio o f CNTs results in strong Van der Waals forces, which
cause them to stick together and form large bundles. There are four major dispersion
methods used in CNTF production: a) use o f surfactant, b) use o f polymers, c) use of
organic solvents and water to fiinctionalize CNTs, and d) use o f DNA, protein, and
starch.
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Using surfactant to disperse CNTs is the most commonly used dispersion method
[152], Any surfactant works by attaching its hydrophobic end to the CNT and pulling the
CNT into a water-like solvent with its hydrophilic tail. A surfactant can be anionic
(produce negative charge in water), cationic (produce positive charge in water) or
nonionic (neutral in water). Triton X-100, sodium dodecyl sulfate (SDS), and sodium
dodecylbenzene sulfonate (NaDDBS) are the most widely used surfactants [153],
Polymers are commonly used in applications which make use o f CNT- polymer
composites [154], [155]. They interact nondestructively with pristine CNTs and maintain
their intrinsic properties. Polymers are not preferred in thin film applications due to their
large size and difficulty to remove them after fabrication.
The biggest advantage o f using organic solvents to disperse CNTs is the minimal
amount of residue found in the final film. The Hansen solubility parameters define the
dispersion state. There are two forces involved when using organic solvents: a) the
attractive Van der Waals forces between CNTs and b) the interactions between the CNTs
and the solvent. Tour et al. have found that the best solvents for dispersing CNTs are 1,2dichorobenzene, chloroform and N-methypyrrolidinone [156].
Using DNA and proteins to disperse CNTs are common in biological applications.
Dispersion o f CNTs in water is highly desirable as it is environmentally friendly and
biocompatible. One way to functionalize CNTs is to treat them with extreme acids that
makes it possible to disperse CNTs in water [157].
9.7.1.2.2

Coating Methods

Once the stable CNT dispersion is made, the next significant challenge is to
uniformly lay down the CNT dispersion on the substrate and dry the solution without
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causing agglomeration. There are many methods that are used to achieve the uniform
coating o f CNTs on the substrate.
The Langmuir-Blodgett (LB) method, also known as “logs-on-a-river” concept is
based on the hydrophobic nature o f CNTs [158]. The first step in this method is to
disperse the CNTs over the surface o f the water; next, the substrate is dipped in the
dispersion and withdrawn horizontally or vertically. This method requires a precise
control over the process, or else the film is easily broken. The other disadvantage is the
time required to achieve more than a monolayer.
The self-assembly (SA) method depends on the interaction between the CNTs and
the substrate. CNTs will adhere to the surface depending on the chemical groups
available on the surface o f the substrate. The surface can be modified with chemicals or
by creating local charges [159], [160]. The chemical functionalization can make use o f
either polar groups such as amino (-N H 2) or carboxyl ( - COOH), or nonpolar groups like
methyl (-C H 3) to modify the substrate. When such a functionalized pre-pattemed
substrate is immersed in the dispersion, the CNTs are attracted to the exposed groups on
the patterns and self-assemble to produce the final pattern. One can also scale up the
process by using this in conjunction with photolithography.
The electrophoretic deposition (EPD) method uses a DC electric field to deposit
CNTs. In this method, a low DC electric field is applied to a conductive substrate the that
helps the CNTs to align themselves linearly and deposit on the electrode [161]. Another
method that employs an electric field to deposit CNTs is Dielectrophoresis (DEP). DEP
uses an AC electric field to deposit and separate CNTs at the same time [162],
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The deposition methods used in the industry involve depositing the dispersion on
the substrate, followed by controlled drying. There are several methods to deposit the
solution on the substrate, which include Mayer Rod, Slot Die, and Gravure [163], [164].
9.7.2

Patterning Carbon Nanotube Thin Films
Most o f the applications using CNTF require some kind o f patterning on the films

to get the desired geometry. For direct growth methods like CVD, a CNT film will grow
only where the catalyst is deposited [165], [166]. So to get a patterned CNTF using direct
growth, the catalyst must be strategically deposited at the patterned sites. Other methods
including photolithography, inkjet printing, and micro contact printing can also be
utilized to pattern the catalyst.
There are two types of solution-based pattern deposition methods: additive and
subtractive. The additive methods are bottom-up approaches that use techniques like
inkjet printing, patterned filtration, and microfluidic channel guided coating [167]—[169].
Subtractive methods are top-down approaches that use techniques like photolithography,
or E-beam lithography, to print a pattern on the thin film, followed by plasma etching or
laser ablation to remove the CNTs from the unprotected part o f the film [170], [171].
Plasma o f Ar, O 2 , CF 4 or CF6 can effectively etch carbon nanotubes. Another interesting
technique to grow patterned thin films combines photolithography and layer-by-layer
self-assembly [172]—[174], The patterns are generated using the conventional
photolithography approach; the substrate is then sequentially dipped into a solution
containing charged CNTs, followed by a solution that has an opposite charge o f the CNT
solution.
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The choice o f patterning methods depends on the type o f substrate, the desired
resolution, and the cost. Subtractive methods, like plasma etching or laser ablation, yield
higher throughput for large-scale device application. High-speed inkjet printing is a very
promising additive technique for large area patterning.
9.7.3

Electronic Properties o f Carbon Nanotube Thin Films
The CNT’s are not aligned for most o f the fabrication techniques used to create

single-walled carbon nanotube thin film (SWCNTF). Due to the interconnected nature o f
CNT’s within the film, a Schottky barrier is created at the junction between two CNTs.
This lack of alignment and existence o f a Schottky barrier can produce SWCNTF with a
wide range o f electrical conductivity. The electrical conductivity o f pure (not
functionalized) SWCNTF ranges from 12.5 S/cm [175] to -10000 S/cm [176].
The conductivity of SWCNTF shows a strong dependence on the film’s thickness
and there is a sharp increase in conductivity beyond a certain thickness. This type of
behavior is a characteristic of percolating network. The percolation threshold (pc), the
conductivity (D), the critical exponent (0), and the concentration of conducting channels
ip) are related as
it oc (p —pc) “ .

Eq. 9-9

Bekyarova et al. demonstrated that, at room temperature, the conductivity data for
their films fits directly to the film thickness (t) according to Eq. 9-9 [144]
a r t w ( t - t c) a,

Eq. 9-10

where t and t< are the film thickness and critical thickness (percolation thickness),
respectively, and Dis a critical exponent. They also found that for non-functionalized
films, the conductivity saturates beyond a certain thickness. In their case, this thickness
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was t ~ 50 nm. For non-covalently functionalized films, the conductivity was an order of
magnitude lower than the non-functionalized films, whereas the conductivity of
covalently functionalized films was two orders of magnitude lower than the nonfunctionalized films. They also observed the percolation threshold for functionalized
films (both covalent and non-covalent) were higher compared to non-functionalized
films. Functionalization introduces increased tunneling barriers between the SWCNTs,
and according to percolation theory, the introduction of insulating substituents dilutes the
concentration of the conducting pathways. This is the reason why the conductivity
decreases and the percolation threshold increases for functionalized SWCNTF.

9.8

Layer-by-Layer Self-Assembly

The layer-by-layer (LBL) technique is a self-assembly process introduced in the
early part o f the 19th century to prepare polyelectrolyte multilayers [177], [178]. This
bottom-up technique is based on the electrostatic adsorption o f charged molecules or
nanoparticles and can be used to achieve some unique geometries and functionalities
[179]—[182]. The solution based molecules or nanoparticles can be assembled on any
substrate, and the entire assembly process can be carried out in a normal laboratory setup.
A thin film o f inorganic nanoparticles assembled by LBL technique is basically
formed by alternate adsorption o f a polyelectrolyte and the inorganic nanoparticle on the
substrate. Every cycle in the assembly process to create one layer consists o f two steps:
incubation and rinse. As shown in Figure 9-17, the charged substrate is immersed into an
oppositely charged polyelectrolyte solution and incubated for a certain time. The
incubation is then followed by a deionized (DI) water rinse, and sometimes an additional
drying step may be added. During the incubation step, the oppositely charged
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polyelectrolyte electrostatically absorbs on the substrate and modifies the original charge
on the substrate, and the subsequent rinse removes the excess polyelectrolyte from the
substrate. Often, to facilitate the production o f thin film assembly, a precursor layer is
assembled prior to the deposition o f the inorganic nanoparticle. This precursor layer is
composed of one or two bilayer o f polyelectrolyte and plays a very vital role in the
efficiency o f the assembly and the time required to assemble the film with a desired
thickness [183].

+ + + + + -

+ -

Solution 1

Solution 2

Figure 9-17: Schematic representation o f electrostatic LBL assembly.

CHAPTER 10

FET BASED BIOSENSOR: DESIGN, MATERIALS, AND
EQUIPMENT NEEDED FOR FABRICATION

10.1

Design

Two types o f devices were fabricated as shown in Figure 10-1 and Figure 10-2.
The type I device has three electrodes: source, drain, and gate, while the type II device
has only two electrodes: source and drain. The type 1 device was fabricated to verify that
the device exhibited a FET-like behavior, while the type II device was used to detect the
biomolecules. Two masks are required to fabricate the type I device. The first mask is to
pattern the source and drain contact electrodes on the silicon wafer, and the second mask
is to pattern the channel between the two electrodes. The type II device utilizes both o f
the masks used in the fabrication o f the type I device and requires an additional mask to
fabricate the gate electrode. All three masks were first designed in AutoCAD and then
converted to the proper GDSII format to feed into the mask writer.
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c

Figure 10-1: a) Schematic top view o f type I device, blue circle highlights the
channel region b) zoom-in view o f the channel region highlighted by
blue circle c) schematic top view o f type II device. The CNTF in the
channel is not shown here.
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Figure 10-2: a) Schematic cross-sectional view o f type I device and b) schematic
cross-sectional view o f type II device. The type I device has three
electrodes: source, drain, and gate, while the type II device has only the
source and drain electrodes.

10.2

Materials

The materials and equipment needed in this project are divided based on the
research cycle: fabrication, characterization, and finally, biomolecule detection.
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10.2.1

Materials Used for Fabrication
The device fabrication in this project uses photolithography techniques in

conjunction with LBL self-assembly. The following is a list o f wafer cleaning chemicals,
photoresists, photoresist developer, and other chemicals used to fabricate the device.
10.2.1.1

Silicon Wafers

The silicon wafers were purchased from Silicon Valley Microelectronics, Inc.
Some o f the important wafer specifications are: diameter: 100+/-0.5 mm, orientation: <10-0>+/-l°, type/dopant: N/As, resistivity: 0.002-0.004 ohm-cm, and film: 2000 A +/-5%
thermal oxide.
10.2.1.2

Ammonium Hydroxide

Ammonium hydroxide assay 28-30 w/w% was purchased from Fisher Scientific.
10.2.1.3

Hvdroeen Peroxide

Hydrogen peroxide, 30% solution, was purchased from EMD Millipore.
Ammonium hydroxide and hydrogen peroxide were used to clean the organic impurities
on the silicon wafer.
10.2.1.4

Shipley S1813

Shipley S I813 is a positive photoresist; upon exposure to light, the interaction
between the molecules is weakened, which makes it easy to strip off the exposed resist
with the help of a developer.
10.2.1.5

LO R 3B

Lift-off resist, LOR 3B, was purchased from MicroChem. LOR 3B when used in
conjunction with a photoresist to create a bilayer can facilitate in a high-yield metal-lift
off process.
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10.2.1.6

MF-319

MF-319 was purchased from DOW Chemical. MF-319 is used to develop patterns
exposed on Shipley 1813 photoresist; it is also capable o f developing LOR 3B.
10-2.1.7

Remover PG

Remover PG was purchased from MicroChem. Remover PG is a solvent stripper
designed to remove photoresists efficiently and completely. It was also used in the lift-off
process as a lift-off solvent.
10.2.1.8

Nitric Acid

Nitric acid, ACS reagent 70%, was purchased from Sigma-Aldrich.
10.2.1.9

Sulphuric Acid

Sulphuric acid, ACS reagent 95-98%, was purchased from Sigma-Aldrich.
10.2.1.10

Membrane Filter

Membrane filter made o f mixed cellulose ester and pore diameter 0.2 microns was
purchased from Whatman GmbH. This filter was used to filter out the acid treated
SWCNTs from the acidic solution.
10.2.1.11

SWCNTs Dispersion in D I Water

The SWCNTs were purchased from Carbon Solutions, Inc. A good dispersion of
SWCNTs in DI water is very important for LBL assembly. To achieve this, 100 mg o f
these tubes were treated with a mixture o f nitric acid and sulphuric acid (1:3 ratios) at 70°
C for 30-45 minutes on a hot plate. The tubes were then filtered out from the acid mixture
using a vacuum filtration setup with the membrane filter. The tubes were then further
washed several times with DI water using the same vacuum filtration setup but changing
the membrane filter. The filtered tubes were then added to 100 mL o f DI water and
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agitated in an ultra-sonic agitator for 1 hour to produce a final dispersion o f 1 mg/mL.
The pH o f the final SWCNTs solution was adjusted to around eight by adding small
volumes o f diluted N H 4 O H . The acid treatment functionalizes the SWCNT with a
carboxyl group as shown in Figure 10-3, and imparts a negative charge on the tubes when
dispersed in DI water. The charge on the SWCNT was measured using a zeta potential
analyzer, and at pH = 8 the charge on the SWCNT was around -60 mV.

O

O

IcI— o

c— o
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Figure 10-3: Functionalized SWCNT with carboxyl group [173],

10.2.1.12

Polv (diallvldimethvl ammonium chloride) solution

Poly (diallyldimethyl ammonium chloride) (PDDA) with structural formula as
shown in Figure 10-4, average Mw200,000-350,000 (medium molecular weight), 20 wt.
% in H20 was purchased from Sigma-Aldrich. PDDA acts as the polycation needed
during LBL self-assembly.

Figure 10-4: Structural formula for PDDA [184].
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10.2.1.13

Poly (,sodium 4-stvrenesulfonate)

Poly (sodium 4-styrenesulfonate) (PSS) powder with structural formula as shown
in Figure 10-5, average M w -70,000, was purchased from Sigma-Aldrich. PSS acts as
the polyanion in LBL assembly.

o=s=o
ONa
Figure 10-5: Structural formula for PSS [185].

1 0 .2 .1 .1 4

Sodium Chloride

Sodium chloride was purchased from Sigma Aldrich. When NaCl is added to
PSS, it helps to shorten the recovery regime during LBL self-assembly [183].
10.2.1.15

Other Chemicals

Acetone and Isopropyl alcohol are used to strip-off resist debris at the end o f the
metal lift-off process and LBL assembly. Deionized (DI) water is used for rinsing the
wafer at various times during the entire fabrication.
10.2.2

Materials Needed for Biomolecule Detection

10.2.2.1

l-Ethvl-3-r3-dimethvlaminopropvllcarbodiimide hydrochloride (EDC)

EDC is a water-soluble zero-length carbodiimide cross-linker that activates
carboxyl groups for spontaneous reaction with primary amines and facilitates the
coupling between them. EDC reacts with a carboxyl to form an amine-reactive Oacylisourea intermediate, but if this intermediate does not encounter an amine, it will
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hydrolyze and regenerate the carboxyl group. EDC was purchased from Thermo
Scientific, and 10 mg o f EDC was added to 1 mL o f DI water.
10.2.2.2

Protein A

Protein A is a protein found in the cell wall o f the bacterium Staphylococcus
aureus. Protein A binds to immunoglobin G (IgG) with high affinity. Four out o f the five
domains in protein A tend to bind with the Fc region o f IgG molecule. Protein A was
purchased from Thermo Scientific.
10.2.2.3

Immunoslubolin G (IsG)

An antibody is a Y-shaped protein as shown in Figure 10-6 that binds highly
specifically with its corresponding antigen. In this work, rabbit IgG was purchased from
Sigma-Aldrich.

IHr

HOOC

o

COOH

Figure 10-6: Structure o f IgG where 1) Fab region, 2) Fc region, 3) heavy chain, 4)
light chain, 5) antigen binding sites, 6) hinge regions [140],
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10.2.2.4

Sea Block

Sea Block blocking buffer was used to prevent non-specific binding o f the IgG on
the sensor surface. Sea Block buffer was purchased from Thermo Scientific.

10.3
10.3.1

Equipment

Equipment Needed for Fabrication
Hot Plate

10.3.1.1

The hot plate was used to dry the wafer after the initial cleaning step. The softbake required for the photoresist and LOR 3B are also done on a hot plate.
10.3.1.2

Spin Coater

The spin coater (manufactured by Cost Effective Equipment) was used to coat
uniform thickness o f photoresist and LOR 3B on the wafer.
10.3.1.3

U V L isht Source and Mask Aliener

SUSS MicroTec mask aligner was used to align the mask and the wafer; the wafer
was then exposed with a UV light source.
10.3.1.4

E-beam Evaporator

The E-beam evaporator from CHA industry was used to deposit chromium (Cr)
and gold (Au) for the contacts.
10.3.1.5

Optical Microscope

An optical microscope was used during various stages o f fabrication to inspect the
patterns on the wafer. The microscope used is Olympus Vannox AHMT3.
10.3.1.6

Vacuum Pump

Vacuum pump in conjunction with membrane filter was used to carry out vacuum
filtration o f acid treated SWCNTs.
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10.3.1.7

Ultra-sonic Asitator

The ultra-sonic agitator (Branson 2510) was used to agitate the final SWCNTs
solution. The agitation helps to get a well-dispersed SWCNTs solution.
10.3.2

Equipment Needed for Characterization and Protein Detection
The device characterization and protein detection was carried out on a Keithley

probe station. We used a zeta-potential measuring device to investigate the charge on the
functionalized SWCNTs; it was also used to investigate the charge on the protein A and
IgG at different pH values.
10.3.3

Other Equipment
A micropipette is useful in dispensing the desired amount o f PBS, protein A, and

IgG during various stages o f the project. A handheld pH meter is also useful in
investigating the pH value of the SWCNTs solution.

CHAPTER 11

FET BASED BIOSENSOR: FABRICATION
The FET based biosensor was fabricated with a combination o f conventional topdown photolithography methods and LBL self-assembly.

11.1

Fabricating the Source and Drain Contact Electrodes

Since both the type I and type II devices require the source and drain contact
electrodes, it was logical to begin fabricating these contacts first. All the devices were
fabricated on a single 100 mm, p-type <100> silicon substrate. The silicon wafer has a
200 nm thick layer of thermally grown oxide. This oxide ensures that the devices
fabricated on the wafer are not electrically shunted at any point during the
characterization or testing phase.
Fabrication o f the source and drain contact electrodes began with cleaning the
silicon wafer. The organic debris on the wafer was cleaned by immersing the wafer in an
aqueous mixture o f ammonium hydroxide, hydrogen peroxide, and DI water (ratio o f 1:
1: 10, respectively) for 20 minutes at a temperature o f 75° C. After 20 minutes the wafer
was taken out of the cleaning solution and first immersed in a bath o f DI water for five
minutes, followed by a thorough rinse under running DI water for one minute. The wafer
was dried by blowing nitrogen and then placed over the hot plate at 115° C for five
minutes to ensure it was completely dry. As shown in Figure 11-1, to create a bilayer o f
102
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LOR and S1813 resist, first a 600 nm thick layer o f LOR 3B was uniformly coated on the
wafer using a spin coater. The wafer was then soft baked at 180° C for three minutes on a
hot plate. After a five minute cool down, a one-micron thick layer o f resist SI 813 was
coated on the wafer. It was then soft-baked on the hot plate at 115° C for 90 s, followed
by a five minute cool down.

S pin c o a t LOR an d positive
p h o to resist

E x p o se th e w afer to th e
so u rce-d rain m a sk

■O xidized
'Silicon

|S 1 8 1 3
D evelop th e e x p o s e d w afer
LOR 3B
E v ap o ra te G old (Au)
G old (Au)
U se R em o v er PG to disso lv e
th e LOR a n d p h oto re sist

□

S o u rce-D rain
M ask

Final stru ctu re:
S o u rc e a n d Drain c o n ta c ts

Figure 11-1: Process flow to fabricate source and drain contacts for type I and type II
devices.

To transfer the pattern o f the source and drain contact electrodes on the wafer, the
source-drain mask was loaded into the mask aligner and then the wafer was exposed for
11 s. The exposed wafer was developed in MF-319 developer solution for 60 s and the
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quality o f the pattern was inspected under an Olympus microscope. The undercut in the
LOR 3B layer is very important for the lift-off process, as a good undercut ensures easy
metal lift-off. The developed wafer was then loaded into an E-beam evaporator to deposit
100 nm of Au. To enhance the adhesion o f Au on silicon oxide, a 50 nm thick layer o f Cr
was deposited prior to the deposition o f Au.
To perform the final metal lift-off step, the wafer was dipped in a bath o f the
Remover PG solution heated to 60° C for three to four hours. A dip in the second bath
greatly helped to remove the unwanted metal layer completely. After inspecting the wafer
under the microscope, the final step was to clean the wafer in IPA and then rinse with DI
water.

11.2

Fabricating the Gate Electrode

The gate contact electrode for the type I device was fabricated using the metal lift
off technique. To create a bilayer o f LOR and SI 813 resist, first a 600 nm thick layer o f
LOR 3B was uniformly coated on the wafer with a spin coater. The wafer was then soft
baked at 180° C for three minutes on a hot plate. After a five minute cool down, a onemicrometer thick layer o f resist S 1813 was coated on the wafer. The wafer was then softbaked on a hot plate at 115° C for 90 s, followed by a five minute cool down.
To transfer the gate pattern on the wafer, the gate mask was loaded into the mask
aligner and then the exposed for 11 s. The exposed wafer was developed in M F-319
developer solution for 60 s and the quality o f the pattern was inspected under an Olympus
microscope. The developed wafer was then loaded into an E-beam evaporator to deposit
150 nm o f Al.
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To perform the final metal lift-off step, the wafer was dipped into a bath o f the
Remover PG solution heated to 60° C for three to four hours. A dip in the second bath
greatly helped to remove the unwanted metal layer completely. After inspecting the wafer
under the microscope, the final step was to clean the wafer in IPA and then to rinse with
DI water.

11.3

Fabricating the Channel

A combination o f photolithography and LBL assembly was used to fabricate the
channel for type I and type II devices. The entire process flow for type II device is shown
in Figure 11-2, and the same process was used to fabricate the channel for the type I
device. The fabrication began with transferring the channel pattern on the wafer. A onemicrometer thick layer o f positive photoresist (SI 813) was spin coated on the wafer and
pre-baked on a hot plate at 115° C for 90 s. The wafer was then exposed to the channel
mask and developed in the MF 319 solution for 60 s followed by a rinse with DI water.
Next the channel was assembled on the patterned wafer using LBL approach.
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Figure 11-2: Process flow to assemble the channel in between the source and drain
for type II device.

For the LBL assembly, polyelectrolyte solutions were prepared by adding 1.4
wt% o f PDDA and 0.3 wt% o f PSS in DI water. To improve the ionic strength, 0.5 M
NaCl was added to the PDDA and PSS solutions. First, a precursor layer was assembled
by alternately immersing the wafer in the aqueous solution o f PDDA and PSS in a
sequence o f [PDDA (10 minutes) + PSS (10 minutes)] 2. The subscript indicates the
number o f cycles; one cycle includes a 10-minute incubation in the PDDA solution, a 30
s rinse in DI water, and 20 s air dry followed by a 10-minute incubation in the PSS
solution, a 30 s rinse in DI water, and 20 s air dry.
The functional reliability o f a SWCNT based FET fabricated by LBL assembly is
much higher if the numbers o f assembled layers are more than four [186]. Following the

107
precursor assembly, the wafer was then alternatively immersed in the aqueous solution o f
PDDA and SWCNTs dispersion in a sequence o f [PDDA (10 minutes) + SWCNTs
solution (10 minutes)] io. After completing the 10th cycle, the wafer was immersed in an
acetone bath to lift-off the unwanted CNTF layer and then rinsed with IPA and DI water.
To improve the current density o f the channel, the wafer was annealed at 115° C for 20
hours in a vacuum. The annealing helps to remove water molecules trapped in the film
and makes quantum mechanical tunneling easier [174].
The thickness o f the CNTF was measured using a Quartz Crystal Microbalance
(QCM, USI System, Japan). The precursor layers and the subsequent layers o f SWCNTs
were assembled on the QCM resonator by following the previously mentioned LBL
assembly protocol. The relationship between the thickness (d) and frequency shift (AF)
was given by [187]:
d ( n m ) = -0 .0 2 2 x AF (Hz).

Eq. 11-1

For the 9-MHz resonator with an effective area o f 0.16 ± 0.01 cm2, the final film
thickness was ~ 95 nm. The optical micrographs o f the devices before and after LBL
assembly are shown in Figure 11-3. The SEM image o f the CNTF with 10 layers is
shown in Figure 11-4.
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Figure 11-3: a) Optical micrograph o f type II device before LBL assembly and b)
optical image o f type II device after LBL assembly. The channel length
is 100 pm, the width is 150 pm and the channel overlap on the source
and drain electrode is 20 pm, and the source and drain electrodes are
made o f Au. c) Optical image o f type I device after LBL assembly, the
source and drain electrodes are made o f Au while the gate electrode is
made o f Al.

Figure 11-4: SEM image o f the CNTF; the CNTF has 10 layers.
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11.4

Passivizing the Source and Drain Contacts

As discussed in Section 9.5.2, the sensing in an immunosensor based on
individual SWCNT is attributed to Schottky Barrier modulation and Electrostatic gating.
To eliminate the influence o f contacts during bio sensing, the source and drain contacts
were passivized. For the type II device, once the channel was assembled between the
source and drain contacts, a one-micrometer thick layer o f SI 813 was spin coated on the
wafer and then baked at 115° C for 90 s. To open a window that exposes only the
channel, the same gate mask used for type I device was utilized. After exposing the wafer
to the gate mask and developing it in MF 319, the wafer was then hard-baked at 115° C
for 60 s. The schematic cross-sectional view o f the passivized type II device is shown in
Figure 1 l-5a, the optical graph o f the actual passivized type II device is shown in Figure
11-5b.

(ft)

Silicon oxide

Silicon substrate

Ill

Fn channeTi
CNTF

Source
Electrode

Drain
Electrode

Figure 11-5: a) Schematic cross-sectional view o f a passivized type II device b)
optical top view image o f actual fabricated device (bottom) showing the
passivized contacts and a window in the middle exposing the microwire
channel only.

Finally, the wafer was diced into individual devices (~ 2 cm x 2 cm) as shown in
Figure 1 l-6a, to use them for sensing bio molecules. A PDMS based fluidic channel can
be incorporated with the device to facilitate the flow o f IgG as shown in Figure 11 -6b.
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Figure 11-6: a) Picture on the top shows an individual device. The size is ~ 2 cm x ~2
cm b) the device with a fluidic channel and tube connection to facilitate
IgG flow.

CHAPTER 12

FET BASED BIOSENSOR: EXPERIMENTAL PROTOCOL,
RESULTS AND DISCUSSION

12.1

Performance of the Device as an FET

Before the device was used as a biosensor to detect biomolecules, it was logical to
test its performance as a transistor. An FET based on individual SWCNT showed a ptype behavior [117] and the same p-type behavior was seen in the FET fabricated by the
LBL assembly o f SWCNTs [186]. As mentioned earlier, the type I device was
specifically fabricated to verify the FET behavior o f the device. The transfer
characteristic o f an FET is a plot o f drain current (Id) variation in response to the change
in gate to source voltage (Vgs); for a p-type device the drain current decreases with an
increase in Vgs. The transfer characteristic o f the type I device was plotted by sweeping
Vgs from -6 V to 6 V and recording the corresponding Id, while maintaining a constant
drain to source voltage (Vds = 4 V). The output characteristic o f the device is shown in
Figure 12-la. As shown in Figure 12-lb, the drain current started to decrease with the
increase in the Vgs, and hence, showed a p-type behavior. The majority carriers in a CNT
are holes. The application of negative gate voltage led to an accumulation o f majority
carriers in the channel and hence the Id increased. The p-type behavior was consistently
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observed in all the fabricated devices and this reliability can be attributed to the relatively
large number o f assembled layers.
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Figure 12-1: a) Output characteristic b) transfer characteristic o f type I device for
drain to source voltage, Vds = 4V. The device gate length is 100 pm and
gate width is 100 pm.
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12.2

Experiment Protocol

For biosensing experiments, only type II devices were used. To prepare the device
for the experiments, first the Protein A (PA) and IgG were reconstituted in 0.01 M o f
PBS solution at a pH o f 7.4. Next, to immobilize PA on the channel, the device with
passivized contacts was treated with the EDC solution for 15 minutes at room
temperature and then rinsed with 0.01 M PBS solution. Following the rinse, the device
was immediately incubated in 1 mg/mL solution o f PA for two hours at room
temperature.
The EDC reacts with a carboxyl group on the SWCNT to form an amine-reactive
O-acylisourea intermediate that spontaneously reacts with primary amines in the PA and
facilitates the coupling between them. The device was then rinsed with PBS to wash off
excess PA, followed by a one-hour incubation in the sea block solution prepared by
adding one part sea block to five parts o f 0.01 M PBS. The sea block ensures the
unoccupied spaces left after PA incubation is not available for further non-specific IgG
bonding on the channel surface. After incubating the device in the sea block for one-hour,
the device was rinsed with 0.01 M PBS and blown dry.
All the electrical measurements were performed by applying a Vds - 10 mV and
recording the drain current in the presence o f the 0.01 M PBS solution. First, the
reference drain current value (current value without any IgG introduced) was recorded by
dropping a 10-pL volume of 0.01 M PBS directly on the device. After recording the
reference current, the device was blown dry and 10-pL volume o f the lowest IgG (IgG l)
concentration was dropped on the device and incubated for 15 minutes, followed by a
PBS rinse and dry. To record the change in drain current caused by the PA-IgGl
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interaction, a 10- jj.L volume o f 0.01 M PBS was dropped on the device and the drain
current was recorded. The 10-pL drop o f PBS present on the device was blown dry and
then alO-pL volume o f the next higher concentration o f the IgG (IgG2) was added and
incubated for 15 minutes, followed by another PBS rinse and dry. Again, the change in
current caused by PA-IgG2 interaction was recorded in the presence o f a 10-pL drop o f
0.01 M PBS solution. After the PBS drop was dried, the device was ready for the next
higher concentration o f IgG. The schematic representation o f the experiment protocol is
shown in Figure 12-2.
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Figure 12-2: Schematic representation o f the protocol a) after Protein A
immobilization on CNTF surface b) after blocking unoccupied spaces
with sea block c) specific bio-affinity interaction between Protein A and
IgG.

12.3

Performance of the Device as a Biosensor

After incubating the device with PA and then using the sea block to block all the
other unoccupied areas left after PA incubation, the device was connected to the Keithley
probe station. As mentioned earlier, a Vds = 1 0 mV was applied in between the drain and
the source, and the reference drain current was recorded after dropping 10-p.L o f 0.01 M
PBS solution directly on to the device. As shown in Figure 12-3, the drain current reaches
an almost steady reference value o f -0.57 pA. The device was then exposed to IgG
starting with the lowest IgG concentration. A 10-pL volume o f 1 pg/mL IgG
concentration was dropped directly on to the device and allowed to incubate for 15
minutes. The device was then rinsed with 0.01 M PBS and dried. The interaction between
PA and IgG is highly specific, where the Fc region o f the IgG binds specifically with the
PA. To record the change in the drain current due to the PA-IgG interaction, a Vds = 10
mV was applied to the device and a 10-pL volume o f 0.01 M PBS solution was dropped
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directly on to the device. The IgG was reconstituted in 0.01 M PBS at pH 7.4, and at this
pH the measured zeta potential o f the IgG was around -11 mV. The specific binding
between PA-IgG on the surface o f the channel in the presence o f a 0.01 M PBS droplet
was then equivalent to applying a negative voltage to the channel. Based on the transfer
characteristics o f the type I device as shown in Figure 12-1, the drain current will
increase with increasing values o f negative gate voltages. For the type II device exposed
to the lowest IgG concentration (~lpg/mL), the drain current also increased by ~ 300 nA.
Further exposure to higher concentrations o f IgG showed a consistent increase in the
drain current value.
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Figure 12-3: Drain current variation in response to various IgG concentrations.

The average value of the drain current for different concentration o f IgG is shown
in Figure 12-4. The absence o f a gate bias for type II device means it operates closer to
the threshold voltage ( V t = 0 V ) where the relationship between the drain current and the
applied gate voltage is non-linear. The initial reference current (current in presence of
PBS only) is for a device without an applied gate voltage. The change in the drain current
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after the addition o f lpg/mL o f IgG is -3 0 0 nA, (Figure 12-3). This can be attributed to
the fact that the addition o f IgG shifts the operating point into the non-linear region,
which causes a big change in drain current. The change in the drain current after the
addition o f 100 pg/mL o f IgG is - 45 nA. The change in the drain current after the
addition o f 1 ng/mL is - 95 nA, and the change in the drain current after the addition of
200 ng/mL is -115 nA. Further addition o f IgG (1 pg/mL) changes the drain current by
only - 80 nA. Once all the available Protein A on the substrate interacts with the added
IgG, the change in current is expected to drop which is what we observed when IgG (1
pg/mL) is added.
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Figure 12-4: Average drain current values for different concentrations o f IgG (three
devices were used during the experiment).

CHAPTER 13

FET BASED BIOSENSOR: CONCLUSIONS AND FUTURE WORK

13.1

Conclusions

To avoid the complications encountered in the fabrication o f biosensors based on
a single CNT, the biosensor was fabricated out o f carbon nanotube thin film. The FET
based biosensor was fabricated using a combination o f photolithography and Layer-byLayer self-assembly. Device characterization confirmed that the fabricated device
behaves like a p-type transistor. Experiments done to investigate the response o f the
device to Protein A-IgG interaction indicated that the device could detect IgG
concentrations that are as low as 1 pg/mL.

13.2

Future Work

The response o f the device could be improved by avoiding the acid treatment
done on the CNTs. This treatment helped to disperse CNTs in water, but it does affect the
electrical properties o f the tubes. The device offers a platform to design sensors for
detecting cancer markers
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